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Abbreviations and Definitions 
µM   micromolar 
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FOXP4  Forkhead-box protein P4 
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GSK3α  glycogen synthase kinase 3α 
GSK3β  glycogen synthase kinase 3β 
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HEK-293T  human embryonic kidney 293T cells 
HSQC  heteronuclear single quantum coherence  
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IDR   intrinsically disordered region 
IPTG   isopropyl-β-D-thiogalactopyranosid 
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kDa   kilo dalton 
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min   minute 
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MRI   magentic Resonance Imaging 
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nm   nanometer 
NMR   nuclear magnetic resonance 
NOESY  nuclear overhauser enhancement spectroscopy 
OD600   optical density at 600 nm 
PBS   phosphate buffered saline 
PIAS   Protein inhibitor of activated STAT 
PKA   protein kinase A 
RNA   ribonucleic acid 
rpm   rotations per minute 
RT   room temperature 
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Abstract (English):  
The transcription factor Forkhead-box-protein P2 (FOXP2) is a highly conserved key 
regulator of embryonal development. Mutations such as R553H in the Forkhead DNA-
binding domain of FOXP2 results a speech disorder. Other mutations result in various 
cancers, indicating that FOXP2 is an important player in signaling pathways. In this 
thesis I investigated FOXP2 function by determining structural features and 
characteristics. In order to understand the regulation of this transcription factor I 
identified new interaction partners, which provide information about the complex 
network of FOXP2 regulation. Beside biophysical methods such as NMR, ITC and 
SAXS I used cell-based assays to further investigate the interaction between FOXP2 
and a crucial player in Wnt-signaling, the co-activator β-catenin. In my studies I 
discovered two interaction sites within FOXP2, one is an intrinsically disordered region 
(IDR) with interesting evolutionary features, as it contains the two residues which differ 
between human and chimpanzee. Next, I found that FOXP2 is forming a back fold 
leading to an intramolecular interaction, which might have impact on interactions with 
other proteins or might influence the DNA-binding affinities and thus the transcriptional 
activity of FOXP2. In order to investigate the effect of β-catenin and the back-fold within 
FOXP2 on the transcriptional activity of FOXP2, I performed RNA-Sequencing. Those 
data revealed not only various signaling pathways but also that both β-catenin and the 
intramolecular interaction affect the transcriptional activity of FOXP2 and thus might 
play an important role in human cells during embryonal development or diseases such 
as cancer. Beside this I discovered a novel phosphorylation site in the IDR region of 
FOXP2, which binds to the interaction partners I found earlier within this project. Using 
NMR I could show, that this phosphorylation is not affecting the interaction between 
FOXP2 and the novel binding partners. This phosphorylation might play a role in the 
regulation of FOXP2 itself or affecting the binding to other interaction partners.  
Summarizing I discovered novel structural features of FOXP2, which play a crucial role 
in its, so far, poorly understood regulation mechanism. Additionally, I found various 
novel interaction partners, which give clues about the interaction network of FOXP2 
and thus help to understand, how FOXP2-linked diseases are developing. I discovered 
a novel phosphorylation site in a region, which is important for protein-protein 
interactions and with evolutionary importance. This novel posttranslational modification 
might be crucial for protein-protein-interactions or the regulation of FOXP2 function.  
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Zusammenfassung: 
Der Transkriptionsfaktor Forkhead-Box Protein P2 (FOXP2) ist ein stark konservierter 
Regulator in embryonaler Entwicklung. Mutationen, wie R553H in der Forkhead-DNA 
bindenden Domäne von FOXP2 führen zu einer Sprachstörung. Andere Mutationen 
führen zu verschiedenen Krebstypen, FOXP2 scheint daher eine wichtige Rolle in 
Signalwegen zu spielen. In dieser Arbeit habe ich die Funktion von FOXP2 durch das 
Bestimmen von strukturellen Eigenschaften untersucht. Um die Regulation dieses 
Transkriptionsfaktors zu verstehen, habe ich neue Interaktionspartner entdeckt, 
welche Indizien auf das komplexe Netzwerk der Regulation von FOXP2 geben. Neben 
biophysikalischen Methoden wie NMR, ITC und SAXS, habe ich zell-basierte 
Methoden verwendet, um die Interaktion zwischen FOXP2 und einem wichtigen 
Protein des Wnt-Signalwegs, dem Co-Aktivator β-catenin, zu untersuchen. In dieser 
Studie konnte ich zwei Bindestellen innerhalb FOXP2 lokalisieren, eine davon ist eine 
unstrukturierte Region mit interessanten evolutionären Eigenschaften, da sie die 
beiden Aminosäuren enthält, welche sich zwischen Mensch und Schimpanse 
unterscheiden. Daneben entdeckte ich, dass FOXP2 mit sich selbst interagieren kann. 
Diese Eigenschaft könnte einen Einfluss auf Interaktionen mit anderen 
Proteininteraktionen oder die DNA-Bindeaffinität haben und so die 
Transkriptionsaktivität von FOXP2 haben. Um den Effekt von β-catenin und der 
Interaktion innerhalb FOXP2s auf die Transkriptionsaktivität von FOXP2 zu 
untersuchen, nutze ich RNA-Seq. Diese Daten zeigten nicht nur einige neue 
Signalwege, aber auch, dass β-catenin und die intramolekulare Interaktion die 
Transkriptionsaktivität von FOXP2 beeinflussen und somit eine wichtige Rolle in Zellen 
während der Embryonalentwicklung oder Krankheiten wie Krebs spielen. Daneben 
entdeckte ich eine neue Phosphorylierung in FOXP2 IDR. Mittels NMR konnte ich 
zeigen, dass diese Phosphorylierung nicht die Bindung zu den anderen entdeckten 
Proteinen beeinflusst. Diese Phosphorylierung könnte eine Rolle bei der Regulation 
von FOXP2 selber spielen oder die Bindung zu anderen Interaktionspartnern 
beeinflussen. Zusammengefasst habe ich neue strukturelle Eigenschaften von FOXP2 
entdeckt, welche eine wichtige Rolle in der, noch wenig verstandenen, 
Regulationsmechanismen spielen könnten. Zusätzlich entdeckte ich einige neue 
Interaktionspartner, welche Informationen auf das Interaktionsnetzwerk von FOXP2 
zulassen und somit helfen, die Entwicklung FOXP2-abhängiger Krankheiten zu 
verstehen. Ich entdeckte eine neue Phosphorylierung, in einer wichtigen Region für 
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Protein-Protein Interaktionen und evolutionären Eigenschaften. Diese neue Post-
translationelle Modifikation könnte wichtig für andere Protein-Protein-Interaktionen 
oder für die Regulation von FOXP2 sein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
List of contents 
1 Introduction ................................................................................................... 12 
1.1 Transcription and transcription factors ............................................................. 13 
1.2 FOX transcription factors .................................................................................. 14   
1.3 Function of FOXP2 ........................................................................................... 15 
1.4 Misfunction of FOXP2 ....................................................................................... 15 
1.5 Evolutionary biology of FOXP2 ......................................................................... 17 
1.6 Animal studies with FOXP2 .............................................................................. 18 
1.7 Structural organization of FOXP2 ..................................................................... 20 
1.8 Regulation of FOXP2........................................................................................ 23 
   1.9 Aim of this thesis ............................................................................................ 26 
2 Material and Methods…………………………………………………………………..28 
   2.1 Material  ........................................................................................................... 29 
2.1.1 Buffer and solutions ....................................................................................... 29 
   2.1.2 Instruments and machines ............................................................................. 32 
   2.2 Methods ........................................................................................................... 34 
   2.2.1 Molecular biological methods ........................................................................ 34 
    2.2.1.1 Plasmid preparation ............................................................................ 34 
    2.2.1.2 Cloning and mutagenesis .................................................................... 34 
    2.2.1.3 Protein expression .............................................................................. 36 
    2.2.1.4 Protein purification .............................................................................. 37 
2.2.1.4 DNA preparation ................................................................................. 38 
   2.2.2 Structural biological methods ......................................................................... 39 
    2.2.2.1 NMR experiments ............................................................................... 39 
   2.2.2.2 CD experiments .................................................................................. 42 
   2.2.2.3 ITC experiments .................................................................................. 42 
      2.2.2.4 SAXS experiments .............................................................................. 43 
  2.2.3 Fluorescence-based methods ........................................................................ 43 
    EMSA .............................................................................................................. 43 
  2.2.4 Cell based methods ........................................................................................ 44 
    2.2.4.1 Cell culture .......................................................................................... 44 
   2.2.4.2 Co-Immunoprecipitation ...................................................................... 44 
   2.2.4.3 RNA isolation ...................................................................................... 44 
11 
 
      2.2.4.4 RNA-Seq preparation and analysis ..................................................... 45 
           2.2.4.5 Real-time RT-PCR .............................................................................. 46 
3 Results ................................................................................................................... 47 
  3.1 Intrinsically disordered region of FOXP2 contains secondary structures    
propensity .................................................................................................................. 48 
  3.2 Region with alpha-helical propensity is a protein-protein interaction site ........... 51 
  3.3 FOXP2 interacts with β-catenin ......................................................................... 54 
  3.4 FOXP2 IDR interacts with FOXP2 FH ............................................................... 65 
  3.5 FOXP2 binds to DNA as dimer and is influenced by intramolecular interaction.75     
  3.6 FOXP2 mediated transcription of Wnt target genes........................................... 83 
  3.7 FOXP2 is regulated by the Wnt signaling pathway ............................................ 92 
  3.8 FOXP2 IDR contains a phosphosite .................................................................. 99 
  3.9 R553H mutant binds to DNA ........................................................................... 107 
4 Discussion .......................................................................................................... 110 
  4.1 FOXP2 contains two protein-protein interaction sites ...................................... 111 
  4.2 FOXP2 is involved in the regulation of the Wnt-signaling pathway .................. 113 
  4.3 FOXP2 is phosphorylated by protein kinase A ................................................ 115 
5 References .......................................................................................................... 117 
6 Appendix ............................................................................................................. 123 
7 Acknowledgement .............................................................................................. 127 
 
 
 
 
 
 
 
 
 
 
12 
 
 
 
 
 
 
 
            
 
             Chapter 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
1. Introduction 
 
1.1 Transcription and transcription factors 
 
The human genome consists of 3.2 billion DNA base pairs which are coding for more 
than 20.000 proteins. Major events such as differentiation, metabolism, communication 
and cell division are the results of the regulation of genetic information in order to 
enable cells to perform target-driven functions and tasks. Thus, each cell type 
containing the identical genomic information, require different proteins for their 
function. For the proper regulation of the expression of those, proteins called 
transcription factors play the most important role on the molecular level. In general, 
protein expression starts with the transcription of a certain DNA sequences into RNA1. 
The process of transcription can be divided in three steps: initiation, elongation and 
termination. During the initiation the enzyme RNA polymerase II binds direct or via 
transcription factors to specific promoter regions on the DNA and unwinds it to the 
single-stranded state2. At a transcription start site a part of the DNA sequence, called 
template strand, is transcribed to mRNA. Transcription initiation is regulated by 
transcription factors, acting either as activators or repressors, which are sometimes 
associated with coactivators or corepressors2. During the elongation the RNA is 
synthesized according to the DNA sequence leading to increasing mRNA molecules2. 
In the last step of transcription, the termination, a polyadenylation occurs in order to 
label the end of the mRNA2,3. Not much is known about the interplay between DNA 
organizing proteins and transcription factors, which enable the recruitment of the RNA 
polymerase to the promoter site of a gene for RNA synthesis. However, studies in 
prokaryotes have shown, that if promoter regions are occupied by other proteins bound 
to DNA, the transcription is disturbed due to the prevention of transcription factor 
binding or DNA separation4-6. In this thesis, the term transcription factor is used to refer 
to transcriptional activators and repressors that affect the transcription of target genes 
via specific promotors regions. Those proteins are defined to contain at least one DNA-
binding domain which is able to bind specific DNA sequences, thereby affecting the 
transcriptional activity of RNA-polymerases and thus the transcription and translation 
of proteins7. In the human genome approximately 2600 proteins contain one or more 
DNA-binding domain assuming that those function as transcription factors8. Thus more 
than 10% of all genes in the human genome code for transcription factors, which 
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makes it the largest protein family in humans. In order to regulate protein expression 
transcription factors stabilize or block the binding of the RNA-polymerase to DNA2, 
recruit coactivators or corepressors to the protein-DNA complex9 and catalyze 
acetylation or deacetylation of histone proteins10. Such signaling pathways are the 
driving force behind many biochemical and molecular networks and thus a key players 
in development and diseases. The understanding of these complex regulatory 
elements just emerged in the last decades. Despite various biochemical and molecular 
biological studies, various key mechanisms still remain elusive.  
 
1.2 FOX transcription factors 
 
Forkhead-Box (FOX) proteins comprise a well conserved class of transcription factor 
proteins in eukaryotes. They are highly diverse in terms of function, ranging from 
proliferation, cell growth, differentiation and longevity to embryonal development and 
homeostasis. Many genes encoding for FOX proteins have been identified and were 
grouped and classified into 19 subclasses (FOXA-FOXS) based on sequence 
conservation11. FOXO-proteins regulate for example metabolism, cell proliferation, 
stress tolerance, cancer and possibly lifespan12-14. FOXG proteins play a role in brain 
and telencephalon development, mutations are linked to microcephaly and brain 
malformations15-17. FOXM gene is known as a human proto-oncogene, the protein 
encoded by this gene is involved in cell cycle progression and cell proliferation18. 
Abnormal upregulation of FOXM1 is involved in oncogenesis of basal cell carcinoma19 
and many other cancers such as liver, breast, lung, colon and brain. FOXP2 protein is 
crucial for language development in human and animals and misregulation are linked 
to cancer20-25. 
 
Until now, 43 FOX proteins with specific functions have been discovered, however, all 
of them harbor a specific motif which is unique for this class of transcription factors: 
the forkhead box domain (later on called FH domain), a sequence of 80 to 100 amino 
acids forming a folded domain that directly binds DNA in a sequence-specific manner.  
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1.3 Function of FOXP2 
 
The family of the FOXP proteins belong to an evolutionary important family of 
transcription factors. The importance of the FH domain has already been described for 
FOXP2 as a point mutation results in an inherited speech disorder (see chapter 1.4). 
As transcription factor, FOXP2 regulates hundreds of genes in various embryonic, 
postnatal and adult tissues, where it plays a role during embryonal development26-28. 
FOXP2 seems to be mainly active in embryonal development, similar to other FOX-
proteins. It has been shown, that FOXP2 regulates genesis of some progenitors and 
neurons in the mammalian cortex, which is known to be a key center for human 
speech29. Besides, it has been found to be expressed in various brain areas such as 
cortical plate, basal ganglia, thalamus, inferior olives and cerebellum and was shown 
to be important for the development of brain areas involved in motor control27. Next to 
its function in brain development, it has also been shown, that FOXP2 plays a role in 
skull shaping and bone remodeling, as well as regulating the strength and length of 
hind limbs and maintenance of joint cartilage30. These recent results lead to the 
conclusion, that FOXP2 might have played a role in the evolution of the human bipedal 
locomotion30. One major functional aspect of FOXP2 activity derives from its 
heterodimerization with its paralogs FOXP1 and FOXP4. A study has shown that 
different combinations of FOXP1/2/4 dimerization severely affect gene expression31. 
This property may have oncogenic consequences.24 FOXP1 and FOXP2 are widely 
co-expressed in specific environments32 and interplay during the embryonal 
development of lung and esophagus33.  
 
1.4 Misfunction of FOXP2 
 
The elucidation of its role in human speech development began with the study of a 
multigenerational British family known as the KE family. Half of the members suffered 
from developmental verbal dyspraxia, an inherited speech disorder. Affected members 
had difficulties in sequencing mouth movements resulting in an inappropriate ability of 
articulation. Beside oral language deficits, also written language was impaired. 
Members with this speech disorder showed difficulties in understanding complex 
language tasks such as grammar, including both expressive and receptive skills34. This 
disorder is caused by a missense mutation localized in the FH domain of FOXP2, which 
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is the only mutation that differ between unaffected and affected members. Hereby, an 
arginine at residue position 553 is replaced by a histidine (R553H) (Fig.1.1).  
 
Fig.1.1: left: schematic representation of location of the point mutation R553H causing the speech 
disorder. Right: X-ray 3D structure of a monomer and dimer FOXP2 FH (green) bound to DNA molecules 
(orange) (PDB code: 2A07). Point mutation is indicated as purple.  
 
This arginine residue seems to be crucial for the DNA-binding properties of this domain 
as it is located close to the DNA binding region (Fig.1.1) and, additionally, responsible 
for the nuclear localization of FOXP235. As a consequence this missense mutation 
leads to a non-functional FOXP236. Additionally, this point mutation causes severe 
changes in the brain organization, especially those brain areas involved in speech. Via 
Magnetic Resonance Imaging (MRI) scientist found different brain regions active in 
patients with the R553H mutation compared to healthy individuals37. Apart from its 
popular role in speech disorders, it has been shown, that FOXP2 is misregulated in 
many cancers. In hepatocellular carcinoma tissue of patients, FOXP2 was significantly 
reduced compared to non-tumorous tissue and linked to poor survival38. Also in breast 
cancer tissue, expression of FOXP2 was lower than in healthy breast tissue and was 
associated to decreased survival. It was shown, that FOXP2 overexpression inhibits 
breast cancer cell migration25, whereas FOXP2 silencing mediates breast cancer 
metastasis39. Thus FOXP2 is a novel suppressor of breast cancer metastasis25. Beside 
those examples showing the suppressive behavior of FOXP2 on cancer progression,  
a few other cancer types has been reported, where overexpression of FOXP2 is linked 
to increased cancer development38,40-42. Also B-cell lymphoma patients showed poorer 
survival, if FOXP2 expression was high43, highlighting the complexity of FOXP2 
function in cell development. Also several other FOX family members are directly 
involved in cancer initiation, maintenance and progression in adults18,40,44. 
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1.5 Evolutionary biology of FOXP2 
 
Via its misfunction as result of certain mutations, FOXP2 has been the first gene found 
to be related to human speech. Human speech is an individual attribute to humans, its 
complex pattern is unique among other animals. Interestingly, the protein coding 
sequence of FOXP2 is among the 5% most-conserved proteins in vertebrates. This 
strong conservation and the strong expression in various, especially fetal, brain regions 
lead to the idea of a strong role in development.  
Between our closest ancestor, the chimpanzee and the humans, FOXP2 differ only 
within two amino acids (substitutions N303T and S325N) (Fig. 1.2). FOXP2 has the 
same sequence in chimpanzee, gorilla and rhesus macaque. Between the mouse and 
human FOXP2 there are only 3 amino acids which differ (E80D, N303T and S325N) 
(Fig. 1.2)45. Thereby the amino acid substitution at position 325 specific for human 
creates a potential phosphorylation site and shows a different secondary structure 
propensity than the sequence of chimpanzee45, which might lead to a different 
regulation of FOXP2 by posttranslational modifications or interaction with co-factors45.  
Interestingly, the one substitution which differs between mouse and chimpanzee 
(E80D) must have occurred during the roughly 130 million years ago (myr) of evolution 
that separated the ancestor of humans and chimpanzee from the mouse. By contrast, 
the two amino acids, which differ between chimpanzee and human, must have 
occurred in the relatively short evolution time of 4.6-6.2 myr, when the human lineage 
diverged from the chimpanzees. The ratio of these changes is significant compared to 
all other lineages harboring the FOXP2 protein. However, the hypothesis, that these 
changes might be a proof of recent positive selection in human evolution, was 
disproven in a recent study46. 
 
18 
 
 
Fig.1.2: protein sequence alignment of FOXP2 in human, chimp, mouse and zebra finch 
(https://www.ebi.ac.uk/Tools/msa/clustalo). Differences between species are indicated with pink 
boxes. 
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1.6 Animal studies on FOXP2 
 
As FOXP2 is involved in speech development of humans, the question raised whether 
FOXP2 is also important for vocalization in other species. The conservation of the 
protein among different species makes it an important evolutionary factor. The human 
ortholog of FOXP2 differs from zebra finch, mouse and chimpanzee orthologs only in 
seven, three or two amino acids, respectively45 (Fig. 1.2). This fact, as well as the fact 
that only humans developed a complex speech pattern, led to studies with various 
animal models. In order to find an appropriate animal model, the learning of 
vocalization must be similar to humans. E.g. zebra finches imitate their parents or 
tutors to learn the species-specific song pattern, which makes them an interesting 
model for human speech development, as humans learn languages by imitating their 
educators. FOXP2 expression levels in the brain of zebra finches are fluctuating 
depending on the period of singing and the age. Zebra finches with FOXP2 knockout47 
or overexpression48 in the striatal song nucleus Area X showed decreased spine 
density and impaired song learning and -production. This lacking imitation ability 
indicates that behavior-linked regulation of FOXP2 is more critical for vocalization than 
absolute FOXP2 levels47-49. Mice are an optimal model to study the function of proteins 
in mammals. To study FOXP2 function in mice, Shu et al. disrupted one or two copies 
of the FOXP2 gene. Those knockout mice showed significantly reduced number of 
ultrasonic vocalizations compared to wildtype mice, suffered from severe motor 
impairments and died within 3 weeks after birth50. Mice carrying the mutation found in 
the affected members of the KE family developed severe motor abnormalities, severe 
impairment of ultrasonic vocalization 51, cerebellar abnormalities and deficits in motor-
skill learning52. Additionally, researchers were interested in the learning abilities of mice 
with the human FOXP2. Schreiweis et al. designed a humanized mouse model, thus 
harboring the human FOXP2, which showed not only differences in striatal 
neuroplasticity but also accelerated learning leading to the conclusion, that the human 
FOXP2 evolution led to differential tuning of corticostriatal systems involved in learning 
processes and thus contributed to adapting the human brain for speech acquisition53. 
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1.7 Structural organization of FOXP2 
 
The protein FOXP2 belongs to the FOXP-family, which consists of four members, 
FOXP1, FOXP2, FOXP3 and FOXP4. All members harbor a zinc-finger, leucine zipper 
and the characteristic Forkhead-domain (Fig.1.3). FOXP1, 2 and 4 share many 
similarities compared to FOXP3, which lacks the poly-Glutamine tract (further on called 
poly-Q).  
 
Fig.1.3: schematic representation of the structural organization of FOXP proteins. Domains are colored 
in different colors, IDRs are colored in grey. 
 
The Forkhead-domain, however, remains conserved in all members, keeping one 
feature for the FOXP-family. FOXP2 is expressed in various organs including lung, gut, 
muscle and liver where it is crucial for the proper embryonal development.  
 
Looking at the domain organization, FOXP2 consists of 715 amino acids forming four 
structured domains which are linked with intrinsically disordered regions (IDRs) 
(Fig.1.4). 
 
 
Fig.1.4: schematic representation of the structural organization of FOXP2. Domains are colored in 
different colors, IDR are colored in grey. 
ZF LZ ForkheadPoly-Glutamine region
ZF LZ ForkheadPoly-Glutamine region
ZF LZ ForkheadPoly-Glutamine region
ZF LZ ForkheadPoly-Prolineregion
FOXP1
FOXP2
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53 
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268 388  409
346  371
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N-terminally it contains a poly-Q, which is the longest of its kind in any human protein 
in healthy individuals54. It stretches from residue 53 to 268 and contains a region with 
40 glutamines in a row. Poly-Q proteins are known to be involved in nuclear localization 
and transcriptional regulation. The most known proteins, which contain poly-Q tracts 
are associated to the development of neurodegenerative disease such as 
Alzheimer’s55, Parkinson’s56  or Huntington’s disease (HD)57. FOXP2 has been shown 
to be linked to HD. A study discovered that knockdown of FOXP2 in healthy mice 
mimicked HD associated behavioral deficits, whereas an overexpression in a mouse 
model with HD associated deficits improved their behavioral phenotype58.  
The second domain forms a zinc-finger from residue 346-371. Zinc fingers are usually 
small and the most common protein motif in the proteome of mammals59-61. Almost half 
of all human transcription factors contain this domain. It functions as promoter of 
protein-DNA, protein-RNA or protein-protein interactions60,62. The tertiary structure of 
zinc fingers is normally stabilized by a zinc ion, but not interfering in the interaction with 
binding partners63. As the affinity from a zinc finger to DNA is normally in the higher 
μM-range64, proteins contain usually a few zinc fingers in a row65-67. However, FOXP2 
contains only one zinc finger domain. Except the primary sequence, not much is known 
about the zinc finger of FOXP2. There is no evidence that this zinc finger is involved in 
DNA or protein binding. Using yeast-two-hybrid system Li et al. showed, that removing 
of the zinc finger do not have significant impact on the transcriptional activity of 
FOXP268. However, for the subfamily member FOXP1, it has been shown, that the zinc 
finger is involved in homo- and heterodimerization69. 
The third domain is a leucine zipper. They are able to form coiled coil motifs with 
hydrophobic parts and thereby promote homo- and heterotypical protein-protein 
interactions70,71. Homodimers bind mostly to palindromic DNA sequences whereas the 
heterodimers are able to bind any combination of DNA sequences72-74. About the 
function of the leucine zipper in FOXP2, not much is known. In the previous mentioned 
study Li et al. showed that the leucine zipper is essential for FOXP2 activity. They also 
hypothesized, that FOXP2 must dimerize for successful DNA binding68. The FOXP 
proteins are conserved and it has been shown, that co-expressed FOXP1, FOXP2 and 
FOXP4 interact with themselves and each other. Studies have indicated, that the 
leucine zipper is necessary for those interactions and thus important for the function of 
FOXP268,75,76.   
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The fourth domain is the forkhead domain (FH), which acts as the main DNA-binding 
domain of FOXP2 and is highly conserved in the FOX family. It is the most studied 
domain of FOXP2 due to its importance in its function. In 2006 Stroud et al. published 
the X-ray structure of the FH bound to DNA77, thereby six FH domains bind as two 
dimers and two monomers to two DNA molecules (Fig.1.5). The two dimers form a so 
called swapping dimer, a known feature in protein complexes. 
 
Fig.1.5: X-ray 3D structure of FOXP2 FH bound to DNA molecules (PDB code: 2A07). Dimers are 
colored in green, monomer in red, DNA in orange. 
 
It has been hypothesized that through this feature FOXP2 is able to bring two remote 
DNA segments close together77. Beside this, studies with S. cerevisiae have shown 
that domain swapping can also regulate the time point of DNA-replication78, thus this 
feature might regulate FOXP2 activity. The dimerization of FOXP proteins is known to 
be unique among FOX proteins, as other FOX transcription factors are known to be 
monomeric upon DNA binding. Compared to other subclasses, the forkhead domain 
of FOXP2 is located at the C-terminus instead of the N-terminus.  
Another structural feature of FOXP2 is the presence of two nuclear localization signals 
(NLS) located in the FH domain35. If one of both NLS is disrupted, the nuclear 
localization is slightly affected but remaining. Only disruption of both NLS lead to the 
abrogation of FOXP2 nucleo-cytoplasmic shuttling35. The R553H mutation, which is 
23 
 
leading to the speech disorder, disrupts the nuclear localization leading to increased 
levels of FOXP2 in the cytoplasm35, the molecular mechanism behind this 
phenomenon remains unclear. In combination with wildtype FOXP2 the mutant version 
can still be imported in the nucleus via heterodimerization with the wildtype protein 
leading to increased levels in the nucleus35.  
 
1.8 Regulation of FOXP2 
 
As it is important for various biological processes, FOXP2 must be tightly regulated. 
So far not much is known about the regulatory processes of FOXP2 and its 
transcriptional activity. A few interaction partners are known such as Protein inhibitor 
of activated STAT (PIAS)75, C-terminal binding protein 1 (CTBP1)79 and Nuclear factor 
of activated T-cells, cytoplasmic 2 (NFATC2)80. 
Additionally, FOXP2 undergoes post-translational modifications such as SUMOylation 
(Small Ubiquitin like modifier)81. A previous study has shown, that this is a crucial 
regulatory mechanism of FOXP2 activity75. Posttranslational modifications (PTMs) are 
important regulators of transcription factors. Thereby functional groups are added to 
certain amino acids to diversify and extend protein function beyond what is dictated by 
gene transcripts82. They reversibly or irreversibly alter the structure and properties of 
proteins through biochemical reactions, leading to diverse functions83. A variety of 
PTMs allow eukaryotic cells to dynamically regulate signaling and physiological 
processes. As analytical methods have improved, the biological influences of many 
types of PTMs have been identified and are characterized in many systems. Besides 
alternative splicing, they provide the proteome with an enormous capacity for biological 
diversity and regulate a plethora of processes including cell growth and differentiation, 
programmed cell death, intracellular transport and cell–cell communication between 
the intracellular and extracellular environment84. In particular PTMs are affecting 
protein-protein interactions, protein-DNA interactions, gene expression and signal 
transduction84. Common types of eukaryotic PTMs that belong to the first class of 
protein modifications are phosphorylation, acetylation, alkylation and glycosylation. 
These PTMs typically occur in ‘regulatory’ protein regions that are intrinsically 
disordered, but also loop regions of folded domains. Intrinsically disordered regions 
(IDRs) are therefore a common target for enzymatic modifications as fast cellular 
signaling responses usually require modifying enzymes to rapidly access individual 
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protein PTM sites, which is easier, when modifiable amino acids are solvent exposed 
such as IDRs85-87. Phosphorylation of serine and threonine residues constitutes the 
most abundant PTM in eukaryotes88,89. 
Disruptions of established PTMs or misregulation of protein kinases are often linked to 
cancers, cardiovascular, brain diseases, diabetes and several metabolic disorders. 
Thus, there have been many studies investigating the mechanism how PTMs regulate 
different cellular signaling processes, in both preventive and curative sense.  
 
For members of the FOXP-family various posttranslational modifications have been 
found, but the effect of those is only known for a few phosphorylations. A 
phosphorylation of a tyrosine in the forkhead domain of FOXP3 is linked to inhibited 
carcinogenesis and transcription, another phosphorylation of S418 is linked to inhibited 
cell growth and induced transcription (https://www.phosphosite.org).  
Phosphorylations, the attachment of a phosphoryl group, occur on serine, threonine 
and tyrosine side chains through a phosphoester bond formation, on histidine, lysine 
and arginine through phosphoamidate bonds, and on aspartic acid and glutamic acid 
through mixed anhydride linkages. This modification forms the most studied PTM in 
eukaryotes, as misregulations of kinases often result in diseases, especially in 
cancer90. Phosphorylations are commonly mediated by enzymes called protein-
kinases, which are also regulated by phosphorylation, thereby forming a dependent 
regulation network. The removal of a phosphate group from a residue is mediated by 
enzymes called phosphatases, making phosphorylations a dynamic regulatory tool91. 
For FOXP2 few PTMs are already known, including six phosphorylated residues 
(Fig.1.6).Only for one FOXP2 phosphorylation the function and effects are known. The 
phosphorylation of the FH domain at position S557, which lies nearby to the mutation 
causing the speech disorder (R553H), was shown to decrease the DNA binding affinity 
of the FH and thus might be involved in the regulation of FOXP2 transcriptional 
activity92.  
 
 
Fig.1.6. known post translational modifications of FOXP2. Phosphorylations (green), Ubiquitination 
(brown), Sumoylation (orange) (derived from https://www.phosphosite.org/). 
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To better understand the regulatory mechanisms which control FOXP2 activity we 
aimed to find clues about pathways, which are regulated by FOXP2 to get ideas about 
regulatory elements and processes in cells. Recently, other FOXP proteins have been 
found to be linked to the Wnt signaling pathway, which raises the question, whether 
and how FOXP proteins are regulated by the Wnt pathway and thus gives new insight 
into human development and mechanism of various diseases like cancer linked to both 
protein families.  
Using Mass-Spectrometry, Walker et al. showed that FOXP1 enhances Wnt signaling, 
an important signal transduction pathway in early embryo development of metazoans, 
by forming a co-complex with β-catenin, Transcription factor 7-like 2 (TCF7L2) and 
CREB (adenosine 3',5'-monophosphate response element-binding protein)-binding 
protein (CBP)93. Also FOXP3 misregulation is linked to the Wnt pathway activation in 
lung cancer by promoting tumor growth and metastasis and forms a complex with β-
catenin, as shown by Co-Immunoprecipitation (Co-IP)94. Wnt signaling operates in both 
vertebrates and invertebrates. The Wnt signaling pathways are central regulatory 
elements in a remarkably diverse range of functions during the embryonic development 
and adult homeostasis controlling cell fate specification95, cell proliferation96,97 and cell 
migration98. Disruptions in this highly-conserved signaling pathway result in various 
diseases including cancer and neurodegenerative diseases99-101.  
 
 
Fig.1.7: schematic representation of the Wnt-signaling pathway. 
 
β-catenin is a crucial player in this pathway acting as transcriptional co-activator for 
many transcription factors. In the inactive state of the Wnt signaling pathway, a protein 
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complex called the β-catenin destruction complex degrades β-catenin continuously in 
the cytoplasm, preventing high β-catenin levels and thus its translocation to the 
nucleus. In the active state the destruction complex is falling apart leading to higher 
cytosolic levels of β-catenin, following its nuclear translocation and acting as activator 
for various transcription factors including the TCF/LEF102-104 pathway, but also FOX 
proteins (Fig.1.7).  
 
Fig.1.8: schematic representation of the structural organization of β-catenin. 
 
Until now, it remains elusive whether or not β-catenin interacts, apart from FOXP1 and 
FOXP3, also with FOXP2. Therefore, in this thesis, I investigated a possible link 
between FOXP2 and the Wnt pathway, as both are important in embryonal 
development. For this aim I focused on the interaction with β-catenin as transcriptional 
co-activator (Fig.1.8), which is regulating, when active, various transcription factors 
such as TCF/LEF102-104, Hypoxia Induced Factor 1 α under hypoxic conditions105 or 
FOXO proteins under oxidative stress106.  
These studies arise the question, whether and how FOXP proteins are regulated by 
the Wnt pathway. Until now, it remains elusive whether or not β-catenin directly interact 
with FOXP proteins and what are the molecular mechanisms allowing regulation of 
FOXP proteins activity and functions.  
  
1.9   Aim of this thesis 
 
In this thesis I describe my PhD project, which was the main project during my doctoral 
studies. For this and all other side projects I used structural biology methods, such as 
solution NMR spectroscopy, Small angle x-ray scattering or isothermal titration 
calorimetry in order to answer specific research questions. All projects intended to 
decipher unprecedented mechanisms in signal transduction, and metabolism 
research. 
FOXP2 is a transcription factor with a huge impact on embryonal development, cancer 
and speech development in humans. It is regulating more than 1000 genes. Due to its 
biological role in animals it must be tightly regulated to ensure the proper transcription 
Armadilloβ-catenin
141 665
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of genes in certain stages of development. So far, its regulation and network is still 
elusive.  
By combining Nuclear magnetic resonance (NMR) spectroscopy and Small-angle X-
ray (SAXS) methods I studied the structural functions of FOXP2 in vitro to obtain more 
information about its function and properties. Next, I was searching for novel binding 
partners interacting with FOXP2 using biophysical methods such as NMR, ITC and 
SAXS, which could regulate FOXP2 activity. To confirm regulatory elements I was 
using cell-based assays such as Co-IP and RNA-Seq to validate the impact of those 
binding-partners on the activity of FOXP2 and thus get more information about its 
function. Beside this I was seeking for novel post translational modifications, which 
could as well play a role in the regulation of FOXP2 using NMR. With all these studies 
I aimed to elucidate the, so far, unknown regulation of FOXP2 in human embryonal 
development and its role in diseases such as cancer, autism and schizophrenia.  
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2  Material and Methods 
 
2.1 Materials 
 
2.1.1 Buffers and solutions 
 
Kanamycin (50 mg/ml)      
5 g Kanamycin (Applichem Panreac) in 100 ml of MilliQ H2O. Filter sterilized. 
 
LB growth medium for E.coli 
2 % (w/v) lysogeny broth (Roth) (+ 0.1 % (v/v) Kanamycin)  
   
10 x salt solution    
1 M KH2PO4 (VWR 99.8%)      
0.5 M K2HPO4 (VWR 99.8%)      
0.6 M Na2HPO4 (Applichem Panreac anhydrous >99%)      
0.14 M K2SO4 (VWR 99-101%)      
pH 7.2 adjusted with HCl (12.2 M) and NaOH (5 M)  
  
Trace element solution   
41 mM CaCl2 x 2 H2O (Applichem Panreac 97%)      
22 mM FeSO4 x 7 H2O (VWR 84%)      
6 mM MnCl2 x 4 H2O (Applichem Panreac)      
3 mM CoCl2 x 6 H2O (Applichem Panreac)      
1 mM ZnSO4 x 7 H2O (VWR 99.9%)  
0.1 mM CuCl2 x 2 H2O (VWR)  
0.2 mM (NH4)6Mo7O24 x 4 H2O (VWR 98.5%)  
17 mM EDTA (Alfa Aesar 99+%)  
 
Minimal medium growth medium for isotope labeled or non-labeled proteins 
900 ml MilliQ H2O      
100 ml 10 x salt solution   
30 
 
5 ml Trace element solution  
5 ml 1 M MgCl2 (Alfa Aesar 99%)  
1g 15NH4Cl (Sigma Aldrich 98%)/2 g 14NH4Cl (Alfa Aesar 99.5%)  
2g 13C6H12O6 (Cambridge Isotope Laboratories 99%)/ 6 g C6H12O6 (Roth 99%)        
0.1% (w/w) Kanamycin (1000x)    
 
Lysis buffer (lysis buffer for structured proteins) 
50 mM Tris (VWR ultra pure)      
150 mM NaCl (VWR 99.6%)      
20 % glycerol (VWR 99%)      
20 mM imidazole (Millipore 99.0%)  
2 mM BME (Roth 98%)     
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M)  
  
Urea lysis buffer (lysis buffer for disordered proteins)  
50 mM Tris (VWR ultra pure)  
150 mM NaCl (VWR 99.6%) 
6 M Urea (Roth >99.5%)  
20 M imidazole (Millipore 99.0%)  
2 mM BME (Roth 98%)     
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M)  
  
Washing Buffer  
50 mM Tris (VWR ultra pure)     
150 mM NaCl (VWR 99.6%)      
20 mM imidazole (Millipore 99.0%)      
2 mM BME (Roth 98%)      
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M)  
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High-salt Washing Buffer  
50 mM Tris (VWR ultra pure)      
1 M NaCl (VWR 99.6%)      
20 mM imidazole (Millipore 99.0%)      
2 mM BME (Roth 98%)     
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M)  
 
Elution Buffer 
50 mM Tris (VWR ultra pure)      
150 mM NaCl (VWR 99.6%)      
500 mM imidazole (Millipore 99.0%)      
2 mM BME (Roth 98%)      
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
 
Phosphate buffer for NMR, ITC and SAXS measurements 
50 mM Na2HPO4/NaH2PO4 (VWR ultra pure)      
150 mM NaCl (VWR 99.6%)      
2 mM BME (Roth 98%)      
pH 6.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
 
Tris buffer for NMR, ITC and SAXS measurements 
50 mM Tris (VWR ultra pure)      
150 mM NaCl (VWR 99.6%)      
2 mM TCEP (Roth 98%)      
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
 
HEPES buffer for ITC and EMSA experiments 
10mM HEPES  
100mM KCl 
2mM BME 
pH 6.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
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Tris buffer for CD experiments 
20mM Tris 
100mM NaF 
0-50% of TFE 
pH 7.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
 
Dye 10X buffer for EMSA experiments:  
10mM Tris 
1mM EDTA 
50% v/v glycerol 
0.001% w/v bromphenol blue 
 
HEPES 10X binding buffer for EMSA experiments: 
100mM HEPES 
10mM EDTA 
1M KCl 
1mM BME 
50% v/v glycerol 
pH 6.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
 
Tris Acetate-EDTA 10X buffer for running gel-electrophoresis 
400mM Tris 
200mM Acetic acid glacial 
10mM EDTA 
pH 6.5 adjusted with HCl (12.2 M) and NaOH (5 M) 
 
2.1.2 Instruments 
FPLC 
Äkta pure (GE Healthcare Life science) 
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NMR spectrometer 
700 MHz Avance III NMR spectrometer (Bruker Biospin) equipped with a TCI 
cryoprobe and 600 MHz Avance Neo NMR spectrometer (Bruker Biospin) equipped 
with a TXI 600S3 probehead. Software for processing: NMRpipe (IBBR) and Topspin 
(Version 4.0.3), Software for analysing: CCPNMR Assignment software (version 
3.0.b1). 
 
SAXS 
SAXSpace (Anton Paar Gmbh), equipped with 1D Mythen Detector, slit collimation, 
cooled Autosampler (ASX), Analysis with the Software SAXSAnalysis (version 
3.00.044). 
 
ITC 
Microcal VP-ITC (Malvern), Analysis with Software Origin (MicroCal, version 7.0). 
 
RNA-Seq  
NextSeq 500 (Illumina), Analysis with Software DESeq2107 
 
q-PCR 
7900HT Fast-Real-Time PCR System (Applied Biosystems, Singapore) 
 
EMSA 
Typhoon 9400, Variable Mode Imager (GE Healtcare Life Science) 
 
 
 
34 
 
2.2 Methods:  
2.2.1. Molecular biological methods:  
 
2.2.1.1 Plasmid preparation 
Plasmids were obtained from Genscript (Piscataway, New Jersey, USA) in desired 
vector. For bacterial expression petM11 vector containing a kanamycin resistance 
gene for positive selection, a z-tag containing a Poly-histidine-tag with TEV-cleavage 
site were used. For mammalian expression the full-length FOXP2 sequence in a 
pCMV-3Tag-1a vector with a SV40 and CMV promoter and kanamycin resistance was 
kindly provided from Prof. Dr. Wolfgang Enard from the Ludwig Maximilians-University 
in Munich. Plasmids were amplified using competent E.coli cells (Top10 from XX) 
cultured in LB-Medium. DNA was then isolated and purified using the Wizard® Plus 
SV Minipreps DNA Purification System (Promega).  
 
2.2.1.2 Cloning and mutagenesis 
Mutations were generated by site-directed mutagenesis using Q5 High-Fidelity 
Polymerase (New England Biolabs).  
For the 50µl PCR the reagents were mixed as follows:  
 
10 µl Q5 High Fidelity DNA Polymerase Buffer (5x)  
1 µl dNTPs (10 mM)  
2.5 µl Forward Primer (10 µM)  
2.5 µl Reverse Primer (10 µM)  
0.25 µl Q5 High Fidelity DNA Polymerase (2 U/µl)  
1 µl DNA Template (20 ng/µl)  
32.75 µl Nuclease-free water  
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Cycling conditions:  
Step 1: Initial Denaturation (98°C) 2 minutes  
Step 2: Denaturation (98°C) 30 seconds  
Step 3: Annealing (primer-dependent) 30 seconds  
Step 4: Extension (72°C) 4.5 minutes  
Go to Step 2 and repeat 25 times 
Step 5: Final Extension (72°C)   
Step 6: 2 minutes Hold (10°C)     
Step 7: ∞  
Following primers were used:  
Construct Primer sequence 5’ to 3’ Optimized for vector 
FOXP2FH Fw1: CGTCCGCCGTTCACCTAC  
Rv1: GGATCCTTATTCCAGGTCTTCTG 
Fw2: CCCGACGCTGtaaAAAAACATTCC 
Rv2: GAGCCGGTAATTTTCTGAC 
E.coli cells pETM11 
FOXP2R553H FW: AAACGCTGTCCACCATAATCTGAG 
RV: TTCCACGTAGCTGCATTAC 
E.coli cells pETM11 
FOXP2503 STOP FW: CGCTGTGTGTAGCCGCCGTTCA 
RV: TTTTTGTAGAATTCGTAGTTC 
E.coli cells pETM11 
FOXP2S330E FW: CCGTCGCGATGAAAGTAGTCATGAG 
RV: GCGCTCAGTACGGAGAGGAT 
E.coli cells pETM11 
FOXP2ΔpolyQ FV: GGTCAGGCCGCACTGCCG 
RV: ATGCAGCAGTTCGACCGTAGAAACTT 
E.coli cells pETM11 
FOXP2247-715 FwW: GGCCAGGCAGCACTTCCT  
Rv: TTAGGTTTCACAAGTCTCGAGTCATT 
Mammalian cells pCMV 3tag 
FOXP2345-715 FW: TCTCTATGGCCATGGAGTTT  
RV: AAGCCGAATTCCACCACA 
Mammalian cells pCMV 3tag 
FOXP2504-715 FW: TCAGACCTCCATTTACTTATGC  
RV: AGCCGAATTCCACCACAC  
Mammalian cells pCMV 3Tag 
FOXP2  
Δ264-272
 
FW: GTGACTGGAGTTCACAGTATG 
RV: AGGACTTAAGCCAGCTTG 
Mammalian cells pCMV 3Tag 
Tab.1: primers used for side-directed mutagenesis 
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PCR efficiency was confirmed by running a 1% Agarose DNA gel with a part of the 
PCR product. 1 µl of DpnI restriction enzyme was added into the PCR tube and mixed 
by pipetting. After incubation at 37°C for one hour, 2 µl of the PCR reaction were mixed 
with 15 µl of Nuclease-free water and heated for 20 minutes at 80°C. 2 µl of 10X T4 
Ligase buffer (NEB) and 1 µl of T4 polynucleotide Kinase (PNK-NEB) were added to 
the chilled tube and incubated for 30 minutes at 37°C. After a ligation step of 2 hours 
at room temperature using 1 µl of T4 Ligase (NEB), the plasmids were transformed 
into competent high copy E.coli cells (Top10) and platted on agarose plates containing 
Kanamycin. Only E.coli cells containing the plasmid are able to grow due to antibiotic 
resistance in plasmid of interest. Colonies were picked from agarose plate after 
incubation overnight at 37°C and DNA was isolated, purified and sent for sequencing 
to GATC biotech (Eurofins genomics). 
 
2.2.1.3 Protein expression  
100 ng of plasmid DNA was added to competent E.coli DE3 cells. After an incubation 
step of 10 min on ice, a heat shock of 42°C for 45 s was applied in an Eppendorf 
thermoblock to introduce the plasmid of interest in the competent cells. Cells were 
incubated on ice for another 5 min to recover from the heat shock. For antibiotic 
resistance development, cells were incubated for one hour in 1 ml of LB media without 
antibiotics at 37°C shaking in an Eppendorf thermoblock. After incubation, 400μl of the 
cell solution were plated on LB-agar plates containing kanamycin for selection and 
incubated overnight at 37°C. Colonies were picked next day and grown in 10 ml of LB 
media + kanamycin for selection at 37°C in an incubator overnight. The overnight 
culture of E.coli DE3 with the genetic information of the protein of interest was used to 
inoculate a main culture (1 L LB media or minimal medium (13C or 12C glucose and/or 
15N or 14N ammonium chloride supplemented) + Kanamycin for selection). When grown 
to an optical density at 600 nm (OD600) of approximately 0.8-1 at 37°C, the protein 
expression was induced with 1 mM IPTG at 20°C overnight. After expression of 
proteins, cells were harvested by centrifugation (15 min, 6000 rpm, 4°C).  
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2.2.1.4 Protein purification 
Harvested E.coli cells were resuspended in 20ml lysis buffer after IPTG-inducted 
protein expression to isolate the recombinant expressed proteins. The pelleted cells 
were then flash-frozen using liquid nitrogen and thawn in a water bath. Cells were 
sonicated for 24 minutes (1s on/1s off; 70 % intensity) in ice-cold water bath and 
centrifuged for 30-45 minutes at 4 °C (12 000 rpm). The supernatant contains all the 
soluble components including the recombinantly expressed protein. In the first step 
proteins were purified using Ni-NTA (Ni-NTA Agarose as stationary phase, Thermo 
Fisher) gravity columns. The purification is based on binding of His-tagged proteins to 
Ni2+ residues in the column. The column was first equilibrated with 25 mL of washing 
buffer and the supernatant of lysed E.coli cells was applied on the column. The flow 
through was collected and applied a second time to obtain a higher yield. Non-
specifically bound proteins were removed by washing the column with approximately 
40 ml of washing buffer and non-specific bound DNA was removed by washing the 
column with 50 mL of high-salt washing buffer. The elution of non-specific proteins was 
monitored using NanoDropTM (Peqlab). The protein of interest was eluted with 10-15 
ml of elution buffer. To avoid a non-native conformation of the protein, the Z-tag was 
removed using TEV protease. The concentration of the eluted protein was determined 
using NanoDropTM (Peqlab) and 2 (w/w) % of TEV protease was added to the protein 
solution. The sample was incubated for at least 8 hours at 4 °C for cleavage. HiPrep 
26/10 Desalting (50 ml, GE Healthcare) on an Äkta pure FPLC system (GE Healthcare) 
was used for buffer exchange. Column was equilibrated with 60 ml of washing buffer 
at a flow rate of 5 ml/min. The protein elution was applied on the column and eluted 
fractions were collected depending on the UV absorbance at 280 nm measured by 
Äkta system detector. In order to avoid Z-tag or TEV protease contamination, the 
protein was applied on a HisTrap (5 mL, GE Healthcare) on an Äkta pure FPLC system 
and the flow through containing the cleaved protein was collected.  
I observed that the protein constructs FOXP2FH and FOXP2R553H still bind with cleaved 
Z-tag to the HisTrap column. The FOXP2 FH was then purified from Z-Tag and TEV 
protease using a HiTrap Heparin HP (5ml) column equilibrated with washing buffer and 
eluted using an increasing gradient of high-salt washing buffer (100 % high-salt buffer 
in 15 ml). 
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The FOXP2R553H construct did not bind to the HiTrap Heparin HP (5ml) column, thus it 
was loaded on a HisTrap and eluted without Z-tag at a washing step with high-salt 
washing buffer before the His-tag was eluted with elution buffer.  
For all experiments, proteins were purified with Size Exclusion Chromatography (SEC). 
High molecular weight constructs were purified using Superdex 200 10/300 Increase 
column, low molecular weight constructs were purified using Superdex 75 300/10 
column in final experimental buffer. 
To obtain higher protein concentrations, Amicon Ultra Centrifugal Filters (Millipore) with 
a cut off of 30 kDa, 10 kDa or 3 kDa were used. Centrifugation steps of 5 – 10 min at 
4 °C at 3500 rpm were followed by mixing of the protein solution in the filter to avoid 
precipitation of the protein due to the concentration gradient. Concentrations of purified 
proteins were determined using NanoDropTM (Peqlab) and the corresponding 
extinction coefficient. 
 
2.2.1.5 DNA preparation: 
For DNA interaction studies we used a target sequence for FOXP2 published by a 
previous publication108. We obtained primers with following sequence from IDT-DNA: 
fw: 5'GCG CTC TTG TTT ACA GCT 3', rv: 5'AGC TGT AAA CAA GAG CGC 3'. The 
obtained DNA was dissolved in desired buffer at a concentration of 1 to 2mM 
concentration. Both primers were mixed at same concentrations and boiled at 95°C for 
10 min and then cooled on ice for 30min to obtain annealed, double-stranded DNA. 
Concentration was then estimated using NanoDropTM (Peqlab) and the extinction 
coefficient. This step was confirmed using 1D 1H NMR spectroscopy, as only double-
strand DNA show up as signal at 13-15ppm.  
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2.2.2 Structural Biological methods 
 
2.2.2.1 NMR experiments 
Interaction experiments: 
The most common NMR experiment for protein-interaction studies is the 1H-15N 
Heteronuclear single quantum coherence (HSQC) spectrum. The obtained signals of 
this experiment represent the H-N correlations of mainly the backbone amide groups, 
but for tryptophan, asparagine and glutamine side chains are also visible. The 1H-15N 
HSQC is regarded as the fingerprint of a protein and looks different depending on the 
chemical environment of the protein. Upon binding of unlabeled interaction partners 
(proteins, peptides, DNA, RNA, small molecules) the chemical environment changes, 
thus the signals differ to the reference spectrum of the labeled protein in absence of 
binding partner.  
For those studies 13C and/or 15N isotopically labelled recombinant proteins were 
produced in E.coli. Samples for NMR measurements contained 100 µM 15N labelled 
FOXP2IDR, FOXP2FH or FOXP2R553H constructs in phosphate buffer with 10% D2O 
added for the lock signal. 1H-15N HSQC NMR spectra were recorded at 298 K on a 600 
MHz Bruker Avance Neo NMR spectrometer equipped with a TXI 600S3 probehead or 
on a 700 MHz Bruker Avance III NMR spectrometer equipped with a TCI cryoprobe. 
NMR spectra with full-length β-catenin were prepared in Tris buffer, as full-length β-
catenin is only stable at a pH of more than 7. All spectra were recorded with a recycle 
delay of 1.0 s, spectral widths of 15.9/30 ppm, centered at 4.7/118.0 ppm in 1H/15N, 
with 1,024 and 256 points, respectively, and 16 scans per increment.  
 
Assignment experiments:  
Assignment experiments are used to identify the different signals obtained from NMR 
experiments such as 1H-15N HSQC and link them to the residues of the studied protein. 
This can be achieved by running triple resonance experiments with NMR and a 15N 13C 
labeled protein sample.  1H-15N pairs are recognized as belonging to neighboring 
residues when corresponding frequencies match. In this way chains of sequentially 
connected residues can be built. This chain might be interrupted by missing NMR 
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signals or invisible residues such as prolines. Afterwards, those chains can then be 
mapped to the protein sequence. The backbone assignment is based on two main 
spectra: HNCACB and HN(CO)CACB. The HNCACB links each NH group with the Cα 
and Cβ chemical shift of its own residue (i) and the preceding residue (i+1), whereas 
the HN(CO)CACB only links NH groups with the Cα Cβ chemical shifts of the residue 
before (i-1). These two experiments are suitable for small to medium proteins, for larger 
proteins the signal-to-noise may not be great and assignment using a HNCA, 
HN(CO)CA, HNCO and HN(CA)CO might be the better experiments. The HNCANNH 
experiment is specific for intrinsically disordered proteins (IDPs), it links the NH group 
of its own (i) with the Cα of the residue before (i-1). 
Three dimensional assignment experiments of FOXP2IDR were recorded on a 600MHz 
Bruker Avance and FOXP2FH were recorded on a 700 MHz Bruker Avance III NMR 
spectrometer, both equipped with a TCI cryoprobe at 298 K. HNCACB spectra 
(hncacbgp3d) were recorded with spectral widths 13.6543/24.00/62.00 ppm, centered 
at 4.7/118/39 ppm in 1H/15N/13C, with 1024, 64, 200 points, respectively. HN(CO)CACB 
spectra (hncocacbgp3d) were recorded with spectral widths 16.02/24.00/62.00 ppm, 
centered at 4.7/118/39 ppm in 1H/15N/13C, with 1024, 64, 200 points, respectively. 
HN(CA)NNH spectra (hncannhgp3d, hncannhgp3d.2) were recorded with spectral 
widths 13.66/24.00/24.00 ppm or 13.66/24.00/4.00 ppm, centered at 4.7/118/118 ppm 
or 4.7/117/4.7 ppm in 1H/15N/13C, with 1024, 64, 200 points or 1024, 64, 100 points, 
respectively. 
 
Chemical shift perturbations:  
Assuming a two-site exchange, the binding of two proteins results in different 
resonance frequencies ωfree and ωbound and their difference Δω=ωbound - ωfree. How the 
different species appear in a spectrum depends on the dissociation constant (Kd) and 
the exchange rate (kex).  
In NMR spectroscopy there are three different exchange regimes based on kex and the 
difference in resonance frequency (Δω). 
• Fast exchange where kex >> | Δω | 
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In fast exchange interaction a single peak appears at a population weighted average 
chemical shifts. 
• Intermediate exchange where kex ~ | Δω | 
In intermediate exchange signals are severely broadened. The position and intensity 
of the peaks are highly uncertain, making the interpretation more complicated. 
• Slow exchange kex << | Δω | 
For interactions in slow exchange each state and the corresponding frequencies can 
be individually observed. 
Secondary structure propensity:  
Assignment of 13Cα and 13Cβ chemical shift were performed on FOXP2 IDR human 
and chimpanzee in order to predict the propensity of the corresponding residues to 
form alpha helix or beta-stranded secondary structure elements. The chemical shifts 
of the protein backbone are sensitive to the local backbone geometry and can therefore 
provide information on the propensity of secondary structural elements. This allows to 
derive secondary structure elements and dihedral angles from chemical shifts. The 
13Cα and Cβ chemical shift difference between FOXP2 IDR and random coil residues 
is dependent on the protein secondary structure and can be calculated using following 
formula: 
Δ =  observed –  random coil 
Random coil chemical shifts were predicted using the ncIDP library, which is optimized 
for IDPs, harboring many proline residues109. Positive chemical shift differences values 
are observed if the corresponding amino-acids tend to form α-helical structures and 
negative values it they are likely to be in a β-stranded secondary structure. Mapping 
the transient secondary structure elements within IDR is essential, as characteristic for 
protein-protein interaction or PTMs sites.  
 
Relaxation experiments: 
1H15N HetNOE experiments were measured for FOXP2 IDR at a concentration of 300 
µM on a 600 MHz Bruker Avance Neo NMR spectrometer equipped with a TXI 600S3 
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probehead at 298 K. Experiments were recorded with spectral widths 16.0176/19.0033 
ppm, d1 3 sec, centered at 4.7/118.5 ppm, with 2048, 512 points.  
 
In-cell phosphorylation experiments:  
Samples for NMR phosphorylation assays contained 50 µM 15N labelled FOXP2 IDR 
constructs in NMR buffer with 300 mM NaCl, 10 mM MgCl2, 0.1 mM EDTA, 5 mM ATP, 
PhosphoSTOPTM (1x, Roche) mixed with 500µl of HEK-lysate (15 mg/ml, estimated 
using Pierce BCA protein assay kit, ThermoFisher) or 500µl of soluble mouse brain 
cell extract (wildtype, C57BI/6) and 10% D2O added for the lock signal. 20 1H 15N 
HSQC NMR spectra were recorded in a row at 298 K on a 600 MHz Bruker Avance 
Neo NMR spectrometer equipped with a TXI 600S3 probehead. All spectra were 
recorded with a recycle delay of 1.0 s, spectral widths of 15.9/30 ppm, centered at 
4.7/118.0 ppm in 1H/15N, with 1,024 and 256 points, respectively, and 16 scans per 
increment.  
 
2.2.2.2 CD experiments 
CD spectra were recorded on a Jasco J-715 Spectropolarimeter spectrometer at 25°C 
between 190 and 260 nm using 15 µM of either human FOXP2 or chimpanzee FOXP2 
in Tris buffer with increasing concentrations of TFE: 0%, 5%, 10%, 15%, 30%, 40% or 
50%. 
 
2.2.2.3 ITC experiments 
For ITC experiments, FOXP2 FH, FOXP2 IDR and β-catenin were prepared in Tris 
buffer and FOXP2 FH, FOXP2 FH-IDR and DNA in HEPES buffer. Binding affinities of 
FOXP2 FH to FOXP2 IDR, β-catenin or DNA were determined at 10 °C with 24 
injections of each 4μl. The concentration in the cell was 10 μM for all measurements, 
the concentrations in the syringe was 100-200 μM, estimated right before the 
measurement using NanoDropTM (Peqlab). The ITC data were analysed with the 
programme MicroCal Origin software version 7.0 and binding information such as 
stoichiometry (N), KD (binding affinity) and ΔH (binding enthalpy) calculated. 
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2.2.2.4 SAXS experiments 
SAXS data were recorded with an in-house SAXS instrument (SAXSspace, Anton 
Paar, Graz, Austria) equipped with a Kratky camera, a sealed X-ray tube source and 
a Mythen2 R 1 K Detector (Dectris). Thereby Axin-1/GSK3ß complex and the buffer 
for background subtraction where loaded via an ASX autosampler and measured in a 
flow cell. The scattering patterns were measured with a 180-min exposure time (180 
frames, each 1 min). Radiation damage was excluded on the basis of a comparison of 
individual frames of the 180-min exposures, wherein no changes were detected. 
Obtained SAXS data were processed using the SAXSanalysis package (Anton Paar, 
version 3.0) and analyzed using the ATSAS package (version 2.8.2, Hamburg, 
Germany). The data were desmeared using GIFT (PCG-Software). The forward 
scattering (I(0)), the radius of gyration (Rg), the maximum dimension (Dmax), and the 
interatomic distance distribution function (P(r)) were computed with GNOM. To 
calculate surface models based on the P(r) functions DAMMIF was employed, which 
uses GNOM files as input. For each structure, 50 simulated annealing runs were and 
the resulting models were superimposed, averaged and filtered using DAMAVER. 
Matching models were then clustered by DAMCLUST. 
 
2.2.3 Fluorescence-based methods 
 
2.2.3.1 EMSA experiments 
EMSA experiments were performed according to the protocol of Hellman and Fried110. 
For studies of FH bound to FAM-labeled DNA a 10% polyacrylamide gel containing 
400mM Tris, 25mM EDTA at pH 7.8, 40% acrylamide-bisacrylamide dd. H2O, 0.05g 
Ammonium persulfate and 12 µL of TEMED were used. FOXP2 FH was prepared in 
HEPES buffer. Fluorescine amidite (FAM)-labeled DNA was ordered as primer from 
IDT DNA GmbH with following target sequence: fw: 5'CGCG CTC TTG TTT ACA GCT 
3', rv: 5'AGC TGT AAA CAA GAG CGCG 3', whereby only the FW primer contained 
the FAM label at the 5’ end, to obtain one label per annealed DNA molecule. Both 
primers (labelled and unlabled) were then dissolved in HEPES buffer to an equal 
concentration, then mixed in equal parts, boiled at 95°C for 10 min and then cooled on 
ice for 30 min. Concentrations was estimated measuring the FAM label with the 
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NanoDropTM (Peqlab) at wavelength 488nm and then calculated by the extinction 
coefficient of the label. Samples were prepared by mixing DNA and FH in different 
ratios with 10X binding buffer. Samples contained 200nM of DNA in each well. FH was 
added in increasing concentrations. Gel was preran with dye-labeled loading buffer to 
determine the migrations pattern for each gel. Samples were then loaded in rinsed 
wells and ran at 50V for 45-60 min. Gels were then removed from gel-chamber and 
DNA was detected using a FAM filter.  
 
2.2.4 Cell-based methods:  
 
2.2.4.1 Cell culture  
Experiments were kindly performed by Dr. Chintan Koyani from the Medical University 
in Graz.  
 
2.2.4.2 Co-Immunoprecipitation 
Experiments were kindly performed by Dr. Chintan Koyani from the Medical University 
in Graz.  
 
2.2.4.3 RNA-Isolation 
RNA was isolated for RNA-Seq analysis and q-PCR analysis. Therefore six conditions 
of each five biological replicates were used: 
1. Condition: mock transfected cells as control 
2. Condition: FOXP2 wildtype overexpression  
3. Condition: CHIR treated cells 
4. Condition: FOXP2Δhelix overexpression 
5. Condition: FOXP2 wildtype overexpression and CHIR treatment 
6. Condition: FOXP2Δhelix overexpression and CHIR treatment 
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U2OS cells were used, as they do not contain endogenous FOXP2 and only 
cytoplasmic β-catenin. CHIR treatment (99021, Tocris) was used to translocate β-
catenin in the nucleus via GSK3 β inhibition.  
 
2.2.4.4 RNA-Seq Preparation and Analysis 
First, RNA integrity and quality was determined using a bioanalyzer instrument (Agilent 
Technologies, Santa Clara, CA, USA). A cDNA library was prepared using the TruSeq 
Stranded mRNA Sample Prep Kit (Illumina Inc., San Diego, USA) according to 
manufactures recommendation. Briefly, 1µg of total RNA was used for first-strand 
synthesis performed on a random hexamer and SuperScript II (Life Technologies, 
Carlsbad, CA, USA). Second-strand synthesis was performed using dUTP and the 
Illumina specific Second Strand Marking Master Mix. After end repair and A-tailing 
indexed adaptors were ligated to the cDNA fragments. Those fragments were then 
enriched using PCR for 15 cycles and purified using AMPure XP Beads (Bechman 
Coulter Inc., Brea, CA, USA). The final libraries were quality checked and quantified 
by q-PCR. On average 61.7 million reads were obtained (range 48-87) per sample. 
The obtained data were analyzed with the DeSeq-bioconductor software in order to 
obtain information about differentially expressed genes. I obtained technical support 
from Christine Beichler and bioinformatical support for the DESeq analysis from Peter 
Ulz and Prof. Ellen Heitzer from the Medical University Graz.  
 
2.2.4.5 Real-time RT-PCR  
To quantify mRNA from chosen genes in the total RNA samples, the Kit Luna Universal 
One-Step RT-qPCR Kit (NEB Laboratory) was used according to the protocol. Therefor 
25ng of total RNA was used as input. For analysis the ΔΔCT-method was performed, 
samples were normalized to the house-keeping gene TBP (Tata-box binding protein) 
and calculated the log2 FC compared to the Mock-transfected cells (cells treated only 
with transfection chemicals).  
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Tab.2: primer sequenes used for q-PCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene  Forward primer (5’-3’) Reverse primer (5’-3’) 
BMP4 ATGATTCCTGGTAACCGAATGC CCCCGTCTCAGGTATCAAACT 
CCND1 GCTGCGAAGTGGAAACCATC CCTCCTTCTGCACACATTTGAA 
CD44 CTGCCGCTTTGCAGGTGTA CATTGTGGGCAAGGTGCTATT 
HPRT1 CCTGGCGTCGTGATTAGTGAT AGACGTTCAGTCCTGTCCATAA 
JUN TCCAAGTGCCGAAAAAGGAAG CGAGTTCTGAGCTTTCAAGGT 
LEF1 TGCCAAATATGAATAACGACCCA GAGAAAAGTGCTCGTCACTGT 
TIAM1 CCTGTGTCTTACACTGACTCTTC CATCCCCGTAAAGCCTGCTC 
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3 Results 
 
3.1 Intrinsically disordered region of FOXP2 contains secondary structures 
propensity 
 
The human isoform and the chimpanzee isoform of FOXP2 differ only in two residues. 
Residue 303 is an asparagine in humans and a threonine in chimpanzee, residue 325 
is a serine in humans and an asparagine in chimpanzees (Fig. 1.2). At the beginning 
of this thesis I was interested in the impact of these two amino acid substitutions on 
the structure of FOXP2, as they seem to have a huge impact on the function of FOXP2. 
For those studies we started with the IDR from residue 247 to residue 341 between 
the poly-Q region and the zinc finger, as this region contains both amino acids which 
differ between human and chimpanzee. Even though the region is intrinsically 
disordered, it can adopt transient secondary structures which might indicate favored 
sites for protein-protein interactions. After expression and purification of FOXP2IDR first 
CD-experiments were performed with both proteins to detect possible secondary 
structures in a fast and simple way. By adding increasing amounts of Trifluorethanol 
(TFE) to the sample the formation of possible secondary structures can be followed. 
TFE is a chemical, which is known to induce and stabilize secondary structures111.  The 
CD experiments in absence of TFE show a curve typical for disordered proteins for 
both, human and chimpanzee FOXP2IDR. The CD curves of α-helical proteins are 
typical and harbor two maxima of CD signals at 208 nm and 222 nm, which can be 
observed with the human FOXP2IDR at 30% TFE. Then, with increasing TFE 
concentration the α-helical propensity of FOXP2IDR becomes stronger so that the signal 
intensity at 208nm and 222nm increases progressively (Fig. 3.1, left). This α-helical 
propensity of the 248-340 disordered region of human FOXP2 is a first clue that this 
region could be involved in protein-protein interaction. 
The same experiment for mouse FOXP2IDR was recorded in order to show potential 
differences to form α-helical structures between human and mouse FOXP2 due to the 
two amino acids substitutions (Fig. 3.1, right). 
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Fig.3.1: CD-spectra of human FOXP2IDR (left graph) and chimpanzee FOXP2IDR (right graph). Curves 
show the structure of FOXP2IDR with different concentrations of TFE as secondary structure inducing 
chemical. 
 
As the effect of TFE is discussed to produce false positive data, NMR was used to 
confirm this secondary structure propensity in absence of TFE. NMR is especially 
useful, as it can not only tell, if there is an α-helix or β-sheet propensity, it can also 
provide information about, which residues are involved in the formation of those 
secondary structures elements. To get these information it is necessary to assign the 
protein of interest. NMR-derived chemical shift values from the 13Cα and Cβ can be 
used to provide information about secondary structure elements propensity (i.e. 
2.2.2.1). Therefore data about chemical shifts of 13Cα and 13Cß nuclei were used in order 
to determine deviations from random coil chemical shifts. Hereby, positive chemical 
shift differences indicate a tendency to form α-helical structures and negative chemical 
shift differences indicate a tendency
 
to form β-stranded structures. After assigning the 
13Cα and Cβ chemical shifts of the IDR of human and chimpanzee FOXP2, the chemical 
shift differences (observed – random coil) were calculated (Fig. 3.2). Indeed, in the 
region of residue 264 to 272 those calculations revealed positive values meaning, that 
in region there is a propensity of forming an α-helix. Negative values would indicate a 
β-sheet formation propensity. As a secondary structure element is not formed by only 
one amino acid, positive or negative calculated values must stretch over at least 4 
amino acids in a row.  
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Fig.3.2: Cα-Cβ chemical shift of FOXP2IDR human and chimpanzee. 
 
In addition, relaxation experiments are a useful tool for the determination of flexibility 
of protein regions. Secondary structure motifs are more rigid, therefore HetNOE values 
are positive, whereas highly flexible disordered regions have largely negative values. 
A hetNOE experiment with 15N labeled IDR of human FOXP2 was recorded to confirm 
the existence of a secondary structure propensity. Hereby, after calculation positive 
values from residue 264 to 272 were observed proving the existence of a less flexible 
region (Fig. 3.3). For the rest of the sequence negative values were observed, which 
proof that the rest is fully disordered.  
 
Fig.3.3: HetNOE experiment indicates a less flexible region between residue 263 and 273 of human 
FOXP2 in agreement with the presence of a secondary structure element in this region. 
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These data indicate that the IDR between the Poly-Q region and the zinc finger of 
FOXP2 indeed shows an α-helical propensity. This secondary structure could be 
necessary for protein-protein interactions and thus an important element in FOXP2 
function.  
  
3.2 Region with α-helical propensity is a protein-protein interaction site 
 
To confirm, that this region is indeed important for binding to other interaction partners 
we used different protein constructs to check possible interactions. FOXP2 plays a 
crucial role in embryonal development and therefore must be tightly regulated, thus 
possible protein partners involved in signaling pathways were tested. As already 
known FOXP193 and FOXP394 are linked to the Wnt signaling pathway. Lymphoid 
enhancer-binding factor 1 (LEF1) is a transcription factor, which is expressed in 
multiple tissues during embryonal development and a key player of the Wnt-/β-catenin 
signaling pathway and its regulation. Thereby it activates the transcription of Wnt 
targets in presence of β-catenin112,113. It contains a β-catenin binding domain at the N-
terminus and a DNA-binding domain called high mobility group box (HMG box) from 
residue 299 to 367102. In order to investigate if LEF1 interacts with FOXP2 and thereby 
competing with β-catenin binding, we used NMR. First, a construct of LEF1 spanning 
from residue 1 to 299 (LEF1-299) was used to determine possible binding events 
between the IDR of FOXP2 and the β-catenin-binding site of LEF1. A 1H 15N HSQC 
reference spectrum with 15N labeled FOXP2IDR was recorded, then increasing amounts 
of unlabeled LEF11-299 was added and further 1H 15N HSQC spectra recorded (Fig. 
3.4). No differences in 1H-15N cross-peak chemical shifts or intensity were detected, 
thus no binding event occurred between both proteins.   
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Fig. 3.4: 1H 15N HSQC with 15N labeled FOXP2IDR, reference (black, 100µM), titrated with unlabeled LEF 
1-299 (olive, 100µM). 
 
Next, the other part of LEF1 from residue 288-399 (LEF288-399), which contains the 
HMG-box domain, was tested. Thereby a reference spectrum of 15N labeled FOXP2IDR 
was recorded and titrated with increasing amounts of unlabeled LEF288-399. Our 
assignment was then used in order to localize the involved binding sites on FOXP2IDR. 
Indeed, chemical shift perturbations (CSPs) of the 1H-15N FOXP2IDR cross-peaks were 
found upon addition of unlabeled LEF288-399 indicating the direct binding of FOXP2IDR 
to LEF288-399 around the residues of FOXP2 which were before found to be involved in 
the α-helix formation (Fig. 3.5).  
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Fig.3.5: Left: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 100µM), titration with unlabeled LEF288-399 
in light blue (200µM). Right: CSP plot of affected residues of FOXP2IDR. 
 
β-catenin interaction protein 1 (ICAT) is known to be a negative regulator of the Wnt 
signaling pathway by preventing the interaction between β-catenin and LEF1114,115. 
Our data have shown a direct interaction between LEF1 and FOXP2, thus we were 
wondering, if there might be competition between ICAT, LEF1 and FOXP2IDR. For this 
another reference spectrum of 15N labeled FOXP2IDR was recorded and increasing 
concentrations of unlabeled ICAT were added. Indeed, CSPs were detected for the 
same FOXP2 residues than those affected by LEF288-399 addition suggesting a 
competition between LEF1 and ICAT for FOXP2 binding (Fig. 3.6).  
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Fig.3.6: Left: 1H 15N HSQC with 15N labeled FOXP2IDR, reference in black, titration with unlabeled ICAT 
in magenta (100µM), orange (200µM) and rose (400µM).  Right: CSP plot of affected residues of 
FOXP2IDR. 
 
 
3.3 FOXP2 interacts with β-catenin 
 
The Wnt signaling pathway was studied extensively in correlation with embryonal and 
cancer development. It has already been show, that few FOX proteins are related to 
the Wnt signaling pathway and, some of them, interacting with a crucial player of the 
Wnt signaling pathway, the transcriptional co-activator β-catenin93,94,106,116,117. As 
FOXP2 functions as transcription factor, is could be regulated by β-catenin, as its 
active form occur in the nucleus upon Wnt-activation. As FOXP193 and FOXP394 were 
shown to interaction with β-catenin via Co-IP, thus enhancing the Wnt signaling 
pathway, we hypothesized that FOXP2 is a novel binding partner of β-catenin.  
In order to determine if β-catenin and the IDR of FOXP2 are interacting, NMR was 
used as fast and sensitive method. A 1H 15N HSQC reference spectrum with 15N 
labeled FOXP2IDR was recorded. Then increasing amounts of unlabeled β-cateninFL 
(β-catenin full-length) was added. The FOXP2 IDR reference spectrum shows less 
signal as compared to the previous ones, as the used buffer had a pH of 7.5. β-catenin 
has  an pI-value of 5.8, thus it is insoluble at a pH of 6.5 or less. As seen in figure 3.7 
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chemical shift perturbations of 1H-15N FOXP2IDR cross-peaks were observed upon β-
catenin addition. 
 
Fig.3.7: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 50µM), titration with unlabeled β-cateninFL (light-
blue, 10µM). 
 
As β-catenin is a co-activator of transcription factors the question arose, if the IDR is 
the only binding site for β-catenin. From the molecular side it would make sense, if β-
catenin would also bind close to the DNA-binding domain in order to affect DNA-
binding and thus the transcription of FOXP2 target genes. To investigate this 
hypothesis 15N labeled FOXP2FH was used and a 1H 15N HSQC was recorded as 
reference. The recorded spectrum displayed characteristic signals for a folded protein. 
Then increasing amounts of unlabeled β-catenin was added. Indeed, CSPs were 
observed indicating the interaction between the FH domain of FOXP2 and β-catenin 
(Fig. 3.8). Thus we found two binding site of β-catenin to FOXP2.  
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Fig.3.8: Above: 1H 15N HSQC with 15N labeled FOXP2FH (black, 50µM), titration with β-cateninFL (light-
blue, 10µM). Below: Intensity plot indicating the binding-affected residues. 
 
In order to validate this interaction in cells Co-IP experiments were used in HEK-293 T 
cells. Both, FOXP2 and β-catenin, are expressed endogenously in this cell type in 
sufficient amounts, thus overexpression was not necessary. Indeed, we could pull-
down β-catenin with FOXP2 antibodies and vice versa. This indicated the interaction 
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could also take place in human cells and at endogenous level (Fig. 3.9, cell culture and 
western blot carried out by Dr. Chintan Koyani from Medical Unversity Graz).    
 
 
Fig.3.9: Co-IP (carried out by Dr. Chintan Koyani, Medical University Graz) of endogenous FOXP2 and 
β-catenin from HEK-293-T cells.  
 
In order to specify the binding site of β-catenin to FOXP2 we used different β-catenin 
constructs. β-catenin contains of a flexible N-terminus, followed by a domain called 
Armadillo region, and a flexible C-terminus. It is known, that the Armadillo domain is 
binding to other IDRs of interaction partners118-121, thus we tried to express and purify 
this folded domain of β-catenin. This construct has been expressed by E.coli but could 
not be concentrated to sufficient concentrations. Thus we continued with another 
construct containing the N-terminal part of the domain from residue 141 to 305 (β-
catenin141-305). This part is known to bind to Axin-1122 and LEF-1123. After recording a 
reference 1H 15N HSQC spectrum with 15N labeled FOXP2IDR increasing concentration 
of unlabeled β-catenin141-305 were added. Indeed, CSPs of 1H 15N FOXP2IDR cross-
peaks were observed, indicating that the N-terminal region of the armadillo domain of 
β-catenin is binding to the IDR of FOXP2 (Fig. 3.10). Using the 1H 15N FOXP2 
backbone assignment the binding site of β-catenin141-305 to the FOXP2IDR could be 
determined at residues 264-272 and thus corresponding to the region with α-helical 
propensity.  
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Fig.3.10: Left: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 50µM), titration with unlabeled β-
catenin141-305 (green, 100µM). Right: Intensity plot of residues of FOXP2IDR indicating the binding region.  
 
Also with 15N labeled β-catenin141-305 and addition of unlabeled FOXP2IDR CSPs of 1H 
15N β-catenin141-305 cross-peaks as well as signals broadening could be detected, 
proofing the interaction between both proteins (Fig. 3.11) 
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Fig.3.11: Left: 1H 15N HSQC with 15N labeled β-catenin141-305 (black, 50µM), titration with unlabeled 
FOXP2IDR (yellow, 100µM). 
 
Next, we also wanted to specify the binding of β-catenin to the FH domain of FOXP2. 
First, the part of β-catenin, which also binds to the IDR, was used. For this 15N labeled 
FOXP2FH was used and increasing amounts of unlabeled β-catenin141-305 added. When 
comparing the reference spectrum with the titration spectra, no differences were 
observed (Fig. 3.12). 
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Fig.3.12: 1H 15N HSQC with 15N labeled FOXP2FH (black, 50µM), titration with unlabeled β-catenin141-305 
(green, 100µM). 
 
Thus, the data show that the part of β-catenin, which binds to the IDR of FOXP2 is not 
binding to the FH domain. Then, the flexible N-terminus of β-catenin, ranging from 
residue 1 to 140 (β-catenin1-140), was used. Indeed, by comparing the reference 
spectrum of the FH to spectra with addition of unlabeled β-catenin1-140 CSPs of 1H 15N 
FOXP2FH cross-peaks as well as signals broadening could be detected proving the 
interaction between the N-terminal IDR of β-catenin and the FH domain of FOXP2 (Fig. 
3.13).  
 
10 9 8 7 6
130
125
120
115
110
50µM FOXP2FH
+ 100µM β-catenin141-305
1H chemical shift (ppm)
15
N
 
ch
e
m
ic
a
l s
hi
ft 
(pp
m
)
β-catenin 141-305 FHX
61 
 
 
Fig.3.13: Above: 1H 15N HSQC with 15N labeled FOXP2FH (black, 100µM), titration with unlabeled β-
catenin1-140 (light purple, 200µM). Below: Intensity plot indicating the binding-affected residues.  
 
To test the C-terminal IDR of β-catenin (residue 666-781, β-catenin666-781), titrations 
with 15N FOXP2FH and unlabeled β-catenin666-781 were also performed. Indeed, also 
here CSPs of 1H 15N FOXP2FH cross-peaks as well as signal broadening indicated the 
interaction between the C-terminal IDR of β-catenin and the FH domain of FOXP2.  In 
order to locate the binding site on the FOXP2 FH domain the obtained 1H 15N NMR 
signals were assigned in order to link each signal to the corresponding residue. Then, 
an intensity ratio plot of the FOXP2FH 1H 15N cross-peaks in free and β-catenin bound 
forms were calculated (Fig. 3.14).  
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Fig.3.14: Above: 1H 15N HSQC with 15N labeled FOXP2FH (black, 100µM), titration with unlabeled β-
catenin666-781 (light blue, 200µM). Below: Intensity plot indicating the affected residues. 
 
Analysis of these intensity ratio plots for both N- and C-terminal part of β-catenin 
showed, that both parts interact with the same residues on the FH (Fig. 3.15).  
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Fig.3.15: overlay of intensities of FH residues bound to β-catenin1-140 and β-catenin666-781 . 
 
In order to investigate the binding regions of β-catenin on FOXP2 in cells, several 
FOXP2 constructs were designed, decreasing size progressively regarding its 
functional domains and regions (Fig. 3.16) and their interaction with endogenous β-
catenin were tested using further Co-IP experiments.  
 
 
Fig.3.16: FOXP2 constructs designed for Co-IP. 
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Fig.3.17: Co-IP using U2OS cells with different overexpressed FOXP2 constructs pulling down 
endogenous β-catenin (carried out by Dr. Chintan Koyani, Medical University Graz). 
 
For this set-up U2OS cells where used, as this cell line contains only endogenous β-
catenin and not FOXP2, thus allowing to examine β-catenin binding only to the 
exogenously expressed FOXP2 constructs. The different FOXP2 constructs were 
overexpressed in comparable amounts and then Co-IP experiments were performed 
using either FOXP2 or β-catenin as bait. As expected due to the previous Co-IP results, 
full-length FOXP2 showed a clear pull-down of β-catenin (Fig. 3.17, cell culture and 
western blot carried out by Dr. Chintan Koyani from Medical Unversity Graz).  Deletion 
of the N-terminal part of FOXP2 from residue 1 to 246, lacking the poly-Q region 
showed similar amounts of co-immunoprecipitated β-catenin compared to the full-
length construct assuming that this region is not involved in β-catenin binding. In 
contrast further deletion of the IDR from residue 247 to 341 showed significantly 
decreased amounts of pulled-down β-catenin suggesting that this FOXP2 region is 
involved in β-catenin binding. Further deletion of the region 342 to 503 containing the 
zinc finger and leucine zipper do not alter the amount of pulled-down β-catenin, 
suggesting that this C-terminal region containing the FH domain is sufficient for β-
catenin binding. Taken together, these results confirm our previous NMR data that not 
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only the FH domain, but also the IDR of FOXP2 around residue 247-341, are both 
involved in the interaction with β-catenin.  
 
3.4 FOXP2IDR is interacting with FOXP2FH 
 
The two binding sites of β-catenin to FOXP2 are not located in physical proximity, 
which raised the question, if there might be a mechanism to bring both binding sites 
close to each other in order to facilitate the binding to β-catenin and other binding 
partners. In order to check if there might be an intramolecular interaction between the 
two β-catenin binding sites, 15N labeled FOXP2IDR was used to record a 1H 15N HSQC, 
then an increasing amount of unlabeled FOXP2FH was added. Indeed, CSPs of 1H 15N 
FOXP2IDR cross-peaks indicated the direct interaction between the IDR and FH of 
FOXP2 (Fig. 3.18).  
 
 
Fig.3.18: Left: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 50µM), titration with unlabeled FOXP2FH 
(coral, 200µM). Right: CSP plot indicating the affected residues around region with α-helical propensity. 
 
Using our NMR assignment the binding site of the FH domain on FOXP2IDR could be 
determined to the region forming the α-helix. To identify the binding site on the FH we 
recorded another 1H 15N HSQC with 15N labeled FOXP2FH and added increasing 
amounts of unlabeled IDR. Also in this direction CSPs of 1H 15N FOXP2FH cross-peaks  
and signal broadening were observed indicating the direct interaction between both 
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protein regions (Fig. 3.19). According to the assignment of the FH the binding site could 
be determined to be partially overlapping with the binding site of β-catenin.  
 
 
Fig.3.19: Above: 1H 15N HSQC with 15N labeled FOXP2FH (black, 100µM), titration with unlabeled 
FOXP2IDR (yellow, 400µM). Below: Right: intensity plot indicating the affected residues. 
  
To test if β-catenin and the FOXP2 FH domain are still interacting, when the FOXP2 
IDR with α-helical propensity is deleted, a construct of FOXP2IDR lacking residue 264-
272 was designed, further called FOXP2IDRΔhelix. First, 15N FOXP2IDRΔhelix was used to 
record a 1H 15N HSQC reference spectrum, then increasing amounts of unlabeled β-
catenin141-305 (Fig. 3.20) or unlabeled FOXP2FH (Fig. 3.21) were added. In both cases, 
no CSPs and signal broadening were detected, proving, that the region with α-helical 
propensity is indeed crucial for the interaction with both partners. 
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Fig.3.20: 1H 15N HSQC with 15N labeled FOXP2IDRΔhelix (black, 50µM), titration with β-catenin141-305  
(green, 100 µM). 
 
 
Fig.3.21: 1H 15N HSQC with 15N labeled FOXP2IDRΔhelix  (black, 50µM), titration with FOXP2FH (coral, 100 
µM). 
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To test, if the intramolecular interaction is affecting the binding to β-catenin, a construct 
containing the FH linked to the region with α-helical propensity (residue 264-272) and 
separated with a GS-linker was designed, further on called FOXP2FH-IDR.  This 
construct should facilitate the intramolecular interaction given their artificial proximity. 
Unfortunately, the expression of full-length FOXP2 was not successful. A reference 1H 
15N HSQC of 15N labeled FOXP2FH-IDR was recorded and β-cateninFL titrated in 
increasing amounts. CSPs of 1H 15N FOXP2FH-IDR cross-peaks  and signal broadening 
were observed proofing the interaction between FOXP2FH-IDR and β-cateninFL (Fig. 
3.22), thus the intramolecular interaction between the IDR and the FH domain of 
FOXP2 is not competitive with FOXP2 binding to β-cateninFL. 
 
 
Fig.3.22: 1H 15N HSQC with 15N labeled FOXP2FH-IDR (black, 50µM), titration with unlabeled β-cateninFL 
light-green, 5µM). 
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As β-cateninFL is often aggregating upon interaction, the shorter, flexible C-terminus of 
β-catenin was used in order to investigate the binding between this part and the FH 
domain of FOXP2 in presence of the region with α-helical propensity. After recording 
a reference 1H 15N HSQC of FOXP2 FH-IDR increasing amounts of β-catenin666-781 where 
added (Fig. 3.23). Signal broadening of 1H 15N FOXP2FH-IDR cross-peaks  were 
observed proofing the direct interaction between the FH-IDR construct and the C-
terminus of β-catenin. 
 
Fig.3.23: 1H 15N HSQC with 15N labeled FOXP2FH-IDR (black, 50µM) titration with unlabeled β-catenin666-
781 (light-blue, 200µM). 
 
Both, β-catenin and the IDR are binding to the same residues of the FH, thus a 
competitive network is possible. Nevertheless, these results indicate, that the 
interaction between FOXP2 and β-catenin is still occurring when the FOXP2 FH 
domain is bound to the IDR region. Therefore, precise binding constant in both states 
should be obtained in order to get more detailed about possible competitive or synergic 
binding modes.  
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To this end ITC was used. ITC is a powerful biophysical method to determine binding 
affinities (KD), binding enthalpy (ΔH) and stoichiometry (N) on the basis of the 
thermodynamic behavior of biomolecule interactions. While ITC is very sensitive to 
strong and semi-strong interactions, it loses its sensitivity when it comes to weaker 
interactions. Thus, interactions with a KD of higher µM range can be detected by NMR, 
but sometimes not by ITC.  
First the interaction between FOXP2IDR versus β-catenin141-305 was tested. Therefore, 
100µM concentrated β-catenin141-305 was step-wise titrated in 10µM concentrated 
FOXP2IDR at a temperature of 10°C leading to temperature changes upon the endo- or 
exothermic interaction (Fig. 3.24).  
 
 
Fig.3.24: Isothermal calorimetry of the binding between β-catenin141-305 (100µM) and FOXP2IDR (10µM) 
at 10°C. 
 
From this experiment a KD of 8µM and a N= 0.98 (stoichiometry) could be calculated, 
but these values should not be taken with caution, as the titration did not show plateaus 
on both ends of the curve meaning that the KD and N could still vary. Next, a titration 
of 100µM FOXP2IDR and 10µM β-cateninFL at 10°C was not giving any signal (Fig.  
3.25).  
Das Bild kann zurzeit nicht angezeigt werden.
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Fig.3.25: Isothermal calorimetry of the binding between FOXP2IDR (100µM) and β-cateninFL (10µM) at 
10°C . 
 
One explanation could be, that β-cateninFL is sensitive to stirring and aggregates fast. 
Next, the interaction between the FH and the N- (Fig. 3.26) and C-terminus (Fig. 3.27) 
of β-catenin was investigated. In the titrations of FH (200µM) vs the N-terminus of β-
catenin (20µM) at 10 °C no signal has been observed. After changing buffers, 
temperatures and concentrations no signal could have been detected. In this case the 
binding seem to be too weak to be detected with ITC. However, the titration between 
FH (200µM) and the C-terminus of β-catenin (20µM) at 10°C resulted in a binding 
signal with a KD of 4µM and N of 1. These results indicate that the C-terminus of β-
catenin binds stronger to the FH than the N-terminus of β-catenin.  
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Fig.3.26: Isothermal calorimetry of the binding between β-catenin1-140 (200µM) and FOXP2FH (20µm) at 
10°C. 
 
Fig.3.27: Isothermal calorimetry of the binding between β-catenin666-781 (200µM) and FOXP2FH (20µM) 
at 10 °C. 
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Then the FOXP2FH-IDR was used to determine if there is a change of affinity to β-
catenin1-140 or β-catenin666-781 compared to the binding between FOXP2FH and those β-
catenin constructs, which could reveal information about the molecular network 
between both proteins. By titrating β-catenin1-140 (200µM) to FOXP2FH-IDR (20µM) at 
10°C no signal was detected (Fig. 3.28), thus, compared to the measurement of β-
catenin1-140 versus FOXP2FH  (Fig. 3.26), the presence of the IDR, and thus the possible 
interaction between FH and IDR does not change the interaction to the N-terminus of 
β-catenin.  
 
 
Fig.3.28: Isothermal calorimetry of the binding between β-catenin1-140 (200µM) and FOXP2FH-IDR (20µM) 
at 10°C. 
 
Then, the interaction between FOXP2 FH-IDR and β-catenin666-781 was investigated.  
By titrating β-catenin666-781 (200µM) to FOXP2FH-IDR (20µM) at 10 °C no signal was 
detected (Fig. 3.29) thus compared to the measurement of β-catenin666-781 versus 
FOXP2FH (Fig. 3.27), the presence of the IDR, and thus the possible interaction 
between FH and IDR does change the interaction to the C-terminus of β-catenin, as 
the interaction between FH and β-catenin666-781 does not take place anymore.  
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Fig.3.29: Isothermal calorimetry of the binding between β-catenin666-781(200µM) and FOXP2FH-IDR (20µM) 
at 10°C. 
 
 
3.5. FOXP2 binds to DNA as dimer and is influenced by the intramolecular 
interaction  
 
To investigate the DNA binding abilities of the FH and the influence of β-catenin and 
the intramolecular backfold NMR, SAXS, ITC and EMSA was used. The DNA target 
sequence was chosen from a FOXP2 target as already published108. First, the binding 
site of the DNA was localized on the FH domain using NMR to check if the interaction 
overlaps with the interaction site of β-catenin and the IDR. Thereby a 1H 15N HSQC of 
15N labeled FOXP2FH was recorded as reference and then added increasing amounts 
of DNA to the sample (Fig. 3.30).  
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Fig.3.30: Above: 1H 15N HSQC with 15N labeled FOXP2FH (black, 100µM), titration with DNA (blue, 
50µM). Below: CSP plots indicating the affected residues. 
 
Indeed, various 1H 15N cross peaks show CSPs and line broadening upon DNA 
addition. Using the FH assignment the binding site could be localized to similar 
residues which are affected by the N- and C-terminus of β-catenin. Not only those, but 
also much more residues were affected. These affected FH residues might not only 
come from the binding to the DNA, but also from the expected dimerization of the FH 
domain77.  
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Fig.3.31: 1H 15N HSQC with 15N labeled FOXP2FH-IDR (black, 100µM), titration with DNA (blue, 50µM). 
 
Then the FOXP2FH-IDR was investigated using NMR in order to detect differences in 
DNA binding compared to the FOXP2 FH domain without present IDR. By comparing 
the reference 1H 15N HSQC of the FH-IDR construct alone or titrated with DNA, various 
CSPs of 1H 15N cross-peaks of the FH-IDR could be detected proofing the interaction 
between the protein with the DNA (Fig. 3.31). Thus the presence of the IDR is not 
preventing the binding of DNA to the FH. Conclusions about affinity differences 
between both constructs to DNA cannot be made here as both constructs are different 
and thus the spectra differ.  
 
To investigate the known dimerization with this DNA target, SAXS was used.  Beside 
samples containing i) only FOXP2FH  and ii) only DNA, iii) equal amounts of FOXP2FH 
and DNA and iv) two equivalent amounts of FOXP2FH and one equivalent DNA were 
recorded in order to characterize the expected dimerization. The buffer-subtracted 
curves already indicated different intensities in the low-q region (Fig. 3.32), assuming 
that there is a difference of size between the FH alone and the FH + DNA.  
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Fig.3.32: Buffer-subtracted raw-curve related to SAXS measurements of FH (225µM, black), DNA 
(225µM, grey), 1:1 ratio of FH:DNA (225µM:225µM, light grey). 
 
Fig.3.33: p(r) curves related to SAXS measurements of FH (black), DNA (grey), 1:1 ratio of FH:DNA 
(light-grey). 
 
The p(r)-curve then confirmed that the mix between FOXP2 FH and DNA indeed leads 
to an increased size of the FH domain upon DNA addition (Fig. 3.33). The porod-
volume then gave insights in the molecular weight of the different samples, which 
resulted in 10kDa for the FH alone, 31kDa for the 2:1 mix between FH:DNA, 29kDa for 
the 1:1 mix and 13kDa for the DNA. These data indicate, that the FH is indeed forming 
a dimer upon DNA binding or that two DNA molecules bind to one FH molecule. 
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In order to investigate the binding affinities, especially in correlation with β-catenin and 
the IDR-induced backfold, ITC was used. A previous study already investigated the 
DNA-binding affinities of the FH of FOXP2 via ITC124. Thereby a KD of 67nM (±4.3nM) 
as binding affinity and a stoichiometry of N= 0.96 was determined between FH and 
DNA124. As the same DNA-sequence and same buffer was used, similar results were 
expected. By titrating the FOXP2FH (100µM) in less-concentrated DNA (10µM) at 10°C 
a strong binding was detected (Fig. 3.34). 
 
 
Fig.3.34: Isothermal calorimetry of the binding between FOXP2FH (100µM) and DNA (10µM) at 10°C. 
 
K : 54 nMD
N: 1.37
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Fig.3.35: Isothermal calorimetry of the binding between FOXP2FH-IDR (100µM) and DNA (10µM) at 10°C. 
 
Our obtained KD of 54nM (± 2.3nM) is similar to the recent published data. The N-value 
gives information about the stoichiometry and thus the number of molecules bound to 
the interaction partner. The obtained N-value was 1.49, which does not directly indicate 
dimerization of the FH upon DNA binding and thus not proofing our SAXS data 
ultimately.  
In order to test if the IDR has an influence on the DNA binding and thus represent a 
regulatory element, the construct FOXP2FH-IDR (100µM) was used and titrated with the 
DNA (10µM) at 10°C (Fig. 3.35). Interestingly, the presence of the IDR result to an 
increased affinity of the FH domain of FOXP2 to the DNA, as we obtained a KD of 9nM 
(±1nM), which suggests that the intramolecular interaction between the FH domain and 
the IDR enhances FOXP2 ability to interact with DNA. The N-value did not differ 
significantly from the previous measurement (N = 1.44).  
Next, the effect of β-catenin on the DNA-binding to the FOXP2FH domain was tested, 
as its role as co-activator for FOXP2 activity is unknown. First, ITC was used in order 
to compare DNA binding of the FOXP2FH in presence of β-cateninFL (Fig. 3.36).  
 
Das Bild kann zurzeit nicht angezeigt werden.
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Fig.3.36: Isothermal calorimetry of the binding between DNA (100µM) and FOXP2FH(10µM) + β-
cateninFL(20mM) at 10°C. 
 
Therefore DNA (100µM) was titrated to FOXP2FH (10µM) at same concentrations as 
above in presence of 2-fold excess of β-cateninFL (20µM) in order to ensure saturation 
of the binding between FOXP2FH and β-catenin. No signal was detected for this 
titration, β-cateninFL resulted in aggregation of the sample in the cell. Thus, the effect 
of the smaller constructs of β-catenin were tested on DNA binding, as they are more 
stable and therefore the results more reliable than with β-cateninFL. By titrating the 
DNA (100µM) in FOXP2FH (10µM) plus a 5-fold excess of β-catenin1-140 (50µM) at 
10°C, no significant signal could be detected. In order to complete the data set DNA 
(100µM) was titrated in FOXP2FH (10µM) plus a 5-dolf excess of β-catenin666-781 
(50µM). Here no signal was detected neither. This indicates, that the interaction of N–
and C-terminus of β-catenin to the FOXP2FH abrogates binding of the FOXP2FH to the 
DNA suggesting that β-catenin is a transcriptional repressor of FOXP2.   
In order to understand the role of the IDR backfold in this process, DNA (100µM) was 
titrated into FOXP2FH-IDR (10µM) plus a 5-fold excess of β-catenin141-305 (50µM) (Fig. 
3.37). The obtained KD of 19nM (±2.7nM) (N=1.67) was different compared to the ITC 
measurement of DNA into FOXP2FH-IDR alone (Fig. 3.35). Here, the presence of β-
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catenin slightly decrease the DNA binding affinity of the FOXP2FH-IDR construct as 
compared to the strong effect on the FOXP2FH alone.  
 
 
Fig.3.37: Isothermal calorimetry of the binding between DNA (100µM) and FOXP2FH-IDR (10µM) + β-
catenin141-305 (30µM) at 10°C. 
 
Another method to detect DNA binding affinities is EMSA. Recently a study published 
EMSA data with FOXP2FH and DNA125. Therefor FAM-labeled DNA was used to be 
detectable with a fluorescence filter. FOXP2FH was added in increasing amounts from 
0µM to 200µM to the DNA and then separated via a bisacrylamid gel (Fig. 3.38, left 
graphic). This gel is not disrupting molecular complexes, thus changes in size can be 
detected. The results show, that upon FH addition, the amounts of free DNA decrease 
and a clear band at higher molecular weight appeared corresponding to a FH-DNA 
complex. At a FOXP2FH concentration of 200µM most of DNA stuck in the well of the 
gel indicating a complex of very high molecular weight.  
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Fig.3.38: EMSA gel of fluorophore-labeled DNA and increasing amounts (0, 1.5, 3.1, 6.1, 12,3, 25, 50, 
100, 200µM) of FOXP2FH (left)  and FOXP2FH-IDR (right). 
 
The same was repeated with the FOXP2FH-IDR construct (Fig. 3.38, right graphic). 
Interestingly, the binding to the DNA seems to be less strong than with the FH alone, 
which does not support the previous ITC-data.  
 
3.6 FOXP2 mediates transcription of Wnt target genes 
 
Until now the complex regulation mechanisms of the transcription factor FOXP2 and 
its broad biological functions remain elusive. To determine possible regulatory 
elements which control FOXP2 activity and discover the biological role of β-catenin 
and the intramolecular interaction in FOXP2 function, we performed RNA-Sequencing 
(RNA-Seq) experiments.  
 
 
Fig.3.39: Western blot (carried out by Dr. Chintan Koyani, Medical University Graz) showing A) Lane 1 
= untransfected U2OS cells, lane 2 = overexpression of FOXP2WT, B) Lane 1 = without CHIR treatment, 
lane 2 = with CHIR treatment in both, cytosolic and nuclear fraction, C) Lane 1 = overexpression of 
FOXP2WT, lane 2 = overexpression of FOXP2Δ-helix. 
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For the set-up U2OS cells were used, as they contain no endogenous FOXP2 and only 
cytoplasmic and thus inactive β-catenin (Fig. 3.39, cell culture and western blot carried 
out by Dr. Chintan Koyani from Medical University Graz). Six conditions were used with 
each 5 replicates (Tab. 3).  
 
Condition Expression 
Control Mock-transfected cells  
FOXP2  FOXP2 WT overexpression 
CHIR CHIR treatment 
FOXP2Δ-helix FOXP2 FOXP2Δ-helix overexpression 
FOXP2 + CHIR FOXP2 WT overexpression + CHIR treatment 
FOXP2Δ-helix + CHIR FOXP2 FOXP2Δ-helix overexpression + CHIR treatment 
Tab.3: overview of conditions used for RNA-Seq in U2OS cells. 
 
The overexpression of FOXP2 (Fig. 3.39A) and the equal expression of FOXP2 
wildtype (WT) and a construct lacking the region with α-helical propensity (FOXP2Δ-
helix) was confirmed by western blot (Fig. 3.39C). 
The chemical CHIR was used to translocate the cytoplasmic β-catenin in the nucleus 
of the U2OS cells in order to affect FOXP2 activity. The successful translocation was 
proven with western blot (Fig. 3.39B). Functional enrichment analysis was performed 
for all differentially expressed genes (DEGs) (FC >2/<-2, p-value <0.05). These data 
resulted in significant enrichment of upregulated and downregulated DEGs. By 
comparing the control with the cells overexpressing FOXP2, 3054 genes were found 
to be significantly upregulated and 4555 genes to be downregulated (Fig. 3.40).  
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Fig.3.40: Volcano plot displaying the up-(red) and downregulated (blue) DEGs of FOXP2 overexpression 
compared to control. 
 
In order to make functional interpretation for the gene expression changes, Gene 
Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was 
performed based on Fisher’s extract test using DAVID 3.8126. The GO database is 
currently the most widely-used gene annotation system for gene functions and 
products and provide a better understanding of the links between genes and 
diseases127. The KEGG database, on the other side, combines genetic information with 
functional information and can thus be used to understand relationships between 
genes and enriched pathways128. 3095 upregulated DEGs were found in 29 significant 
KEGG pathways. ‘PI3K-Akt signaling pathway’ was the pathway with most genes 
involved (51 genes) (Tab.4). 
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Tab.4: List of most significant up- and downregulated KEGG pathways and biological functions upon 
FOXP2 overexpression compared to control. 
 
Additionally, 136 significant biological functions were found. The biological function 
with most genes was ‘signal transduction’ (152 genes). 4555 downregulated genes 
were associated with 31 significant pathways (KEGG) and 222 biological functions. 
The pathway with most genes involved was ‘pathways in cancer’ (76 genes) and the 
biological function with most genes was ‘cell adhesion’ (130 genes). Interestingly, in 
the gene set of the downregulated genes Wnt-related GO-terms appeared in five 
biological functions as ‘Wnt signaling pathway’ (p-value: 0.0013), ‘negative regulation 
of Wnt signaling pathway’ (p-value: 0.0083), ‘negative regulation of canonical Wnt 
signaling pathway’ (p-value: 0.021), ‘Wnt signaling pathway, calcium modulating 
KEGG 
pathways 
Upregulated Downregulated 
 Ribosome biogenesis in eukaryotes Axon guidance 
 TNF signaling pathway ECM-receptor interaction 
 NF-kappa β signaling pathway Basal cell carcinoma 
 Cytokine-cytokine receptor 
interaction 
Cell adhesion molecules (CAMs) 
 RNA transport Arrythmogenic right centricular 
cardiomyopathy 
 Legionellosis Pathways in cancer 
 Apoptosis Hypertrophic cardiomyopathy 
 NOD-like receptor signaling pathway Calcium signaling pathway 
 Hematopoietic cell lineage Hippo signaling pathway 
 MAPK signaling pathway Dilated cardiomyopathy 
   
Biological 
functions 
  
 rRNA processing Homophilic cell adhesion 
 Inflammatory response Cell adhesion 
 Ion transport Extracellular matrix organization 
 Response to liposaccharides Nervous system development 
 Sodium ion transmembrane transport Synapse assembly 
 Maturation of SSU-rRNA Calcium-dependent cell-cell adhesion 
 Neurotransmitter transport Heart development 
 Cellular response to liposaccharide Negative regulation of gene expression 
 Ion transmembrane transport Glycosaminoglycan catabolic process 
 Ribosomal large subunit biogenesis Axon guidance 
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pathway’ (p-value: 0.033) and ‘positive regulation of Wnt signaling pathway, planar cell 
polarity pathway’ (p-value: 0.058). Additionally, it was found in the Top 15 of the KEGG 
pathway analysis leading to a strong effect of FOXP2 overexpression on Wnt-
pathways. To get a more specific idea of the effect of FOXP2 on the Wnt-pathway the 
expression of 25 known Wnt targets in the RNA-Seq data set was visualized in a 
heatmap (Fig. 3.38). FOXP2 overexpression significantly changes the expression of 
17 observed Wnt targets giving a first clue about the regulation mechanisms of FOXP2. 
Visualization in a heatmap shows the effect of FOXP2 overexpression on those genes 
(Fig. 3.41). 
To validate the gene expression changes from the RNA-Seq data real-time q-PCR was 
performed on a list of few Wnt targets. As expected, the expression levels of the 
selected genes were similar to the RNA-Seq data confirming the previous results (Fig. 
3.42).   
 
 
Fig.3.41: Heatmap of Wnt genes changed by FOXP2 overexpression compared to control, colors 
indicate normalized log2 FC values, negative (blue), positive (red), neutral (white).  
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Fig.3.42: q-PCR quantification of Wnt genes changed by FOXP2 overexpression compared to control. 
 
In order to assess the role of the intramolecular interaction between the IDR with α-
helical propensity and the FH of FOXP2 and its effect on the regulation of its function 
we performed RNA-Seq analysis on cells expressing a FOXP2 construct lacking the 
α-helix element in this IDR (further called FOXP2Δ-helix). By comparing the genes 
changed between FOXP2 fulllength compared to control and FOXP2Δ-helix compared 
to control various differences were found between both data sets (Fig. 3.43).  
 
 
Fig.3.43: Left: Venn diagram showing the differences between FOXP2 and FOXP2Δ-helix, both compared 
to the control. Right: Volcano plot showing significantly up-(red) and downregulated (blue) genes 
compared to control. 
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Next, KEGG-pathway and GO term biological function analysis was performed on this 
data set (Tab.5). Interestingly, the biological function with most upregulated genes was 
‘signal transduction’ (166 genes involved, 8,6e-6). Compared to the wildtype FOXP2, 
FOXP2Δ-helix showed only once the Wnt signaling pathway in the significant different 
KEGG pathways and biological functions (Tab.5).  
 
Tab.5: List of most significant up- and downregulated KEGG pathways and biological functions upon 
FOXP2Δ-helix overexpression compared to control. 
 
KEGG 
pathways 
Upregulated Downregulated 
 Ribosome biogenesis in eukaryotes Pathways in cancer 
 MAPK signaling pathway ECM-receptor interaction 
 TNF signaling pathway Axon guidance 
 NF-kappa B signaling pathway Basal cell carcinoma 
 Cytokine-cytokine receptor 
interaction 
Focal adhesion 
 Mineral absorption ABC transporter 
 Transcriptional misregulations in 
cancer 
Arrythmogenic right ventricular 
cardiomyopathy (ARVC) 
 Hematopoietic cell lineage PI3K-Akt signaling pathway 
 Bile secretion Dilated cardiomyopathy 
 Legionellosis Hypertrophic cardiomyopathy (HCM) 
   
Biological 
functions 
  
 rRNA processing Homophilic cell adhesion 
 Angiogenesis Cell adhesion 
 Maturation of LCU-rRNA Nervous system development 
 Signal transduction Extracellular matrix organization 
 Mitochondrial translational 
elongation 
Synapse assembly 
 Response to cAMP Skeletal system development 
 Response to cytokine Chemical synaptic transmission 
 Mitochondrial translational 
termination 
Calcium-dependent cell-cell adhesion 
 Apoptotic mitochondrial changes Axon guidance 
 Mitochondrion organization Negative regulation of endopeptidase activity 
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66% of 3656 upregulated genes in total were similar between both constructs. 618 
genes were unique for FOXP2 full-length and 602 genes were unique for the FOXP2 
Δα-helix construct.  
70% a total of 5012 genes, which were downregulated, were similar in both conditions. 
1012 genes were unique for FOXP2 full-length and 457 genes were unique for 
FOXP2Δ-helix. The heatmap in Fig. 3.44 shows the effect of FOXP2Δ-helix on a selection 
of Wnt-target genes. Not much differences could be detected between both data sets. 
 
Fig.3.44: Heatmap of Wnt genes changed by FOXP2 and FOXP2Δ-helix overexpression compared to 
control, colors indicate normalized log2 FC values, negative (blue), positive (red), neutral (white).  
  
Q-PCR showed, that there are very slight differences between a few selected Wnt 
targets. (Fig. 3.45) 
 
90 
 
 
Fig.3.45: q-PCR quantification of Wnt genes changed by FOXP2 or FOXP2Δ-helix overexpression 
compared to control. 
 
As these comparisons do not show accurately the specific differences between FOXP2 
and FOXP2Δ-helix expressing cells, as they only show the differences of each condition 
compared to the control cells, the genes of the FOXP2 condition were directly 
compared to the FOXP2Δ-helix condition to detect all differences between both (Fig. 
3.46).  
 
 
Fig.3.46: Volcano plot showing significantly up-(red) and downregulated (blue) genes of FOXP2Δ-helix 
compared to FOXP2. 
 
Here much less genes were found to be differentially expressed compared to the 
comparisons before. Thus, in comparison to FOXP2 156 genes were found to be 
significantly up- and 362 genes downregulated in the FOXP2Δ-helix condition. For the 
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upregulated fraction 9 biological pathways and none KEGG pathways were found to 
be involved. The biological function with most genes was ‘immune response’. For the 
downregulated fraction 24 biological functions and 11 KEGG pathways were found to 
be involved. Interestingly, the biological function with most genes was ‘signal 
transduction’ and the KEGG pathway with most genes the ‘MAPK signaling pathway’. 
Thus more genes are downregulated with the FOXP2 construct lacking the α-helix, 
thus the backfold indeed seem to have a regulatory effect on FOXP2 activity either due 
to the intramolecular interaction or the interaction with FOXP2 binding partners. 
 
3.7 FOXP2 is regulated by the Wnt signaling pathway  
 
To investigate the effect of β-catenin on FOXP2 transcriptional activity, a part of the 
cells was treated with CHIR and compared to cells only expressing FOXP2 and cells 
only treated with CHIR. This chemical is inhibiting both kinases GSK3α and GSK3β, 
which are responsible for the cytoplasmic phosphorylation of β-catenin and thus play 
a crucial role in cellular β-catenin degradation. Using CHIR we were able to enrich β-
catenin in the nucleus due to its accumulation in the cytoplasm (Fig. 3.39B).  
In order to find clues about β-catenin associated regulation of FOXP2 function the gene 
sets of FOXP2, CHIR and FOXP2 + CHIR, each compared to the control were 
compared (Fig. 3.47).  
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Fig 3.47: Left: Venn diagram showing the differences between FOXP2, CHIR and FOXP2 + CHIR, all 
compared to the control. Right: Volcano plot showing significantly up-(red) and downregulated (blue) 
genes of each condition compared to control. 
 
Thereby in the upregulated fraction 798 genes were found to be similar in all data sets. 
499 genes were unique for FOXP2, 716 unique for CHIR. More importantly 1913 genes 
were unique for FOXP2 + CHIR, thus could highlight β-catenin dependent regulation 
of FOXP2 function and vice-versa. 1704 genes were similar in both FOXP2 and FOXP2 
+ CHIR, leading to the suggestion, that those genes are FOXP2 dependent but β-
catenin independent. The smallest fraction of genes is similar between FOXP2 and 
CHIR. In the downregulated part the fraction with most genes was found to be similar 
in all conditions (1795). The second largest fraction is similar between FOXP2 and 
FOXP2 + CHIR (1554). 905 genes were unique for FOXP2, 767 unique for CHIR and 
833 unique for FOXP2 + CHIR. In Tab. 6 the most significant KEGG pathways and 
biological functions are displayed, derived from genes, which only show up in the 
FOXP2+CHIR condition. Interestingly, Wnt related pathways did not showed up 
significantly. 
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Tab.6: List of most significant up- and downregulated KEGG pathways and biological functions upon 
FOXP2 overexpression + CHIR treatment compared to control. 
 
In the heatmap the effect of the CHIR treatment on the conditions is visualized (Fig. 
3.48). The condition with FOXP2 + CHIR is supposed to display the effect of the 
interaction between FOXP2 and β-catenin. The confirmation by q-PCR supported the 
previous RNA-Seq data (Fig. 3.49).  
 
KEGG 
pathways 
Upregulated Downregulated 
 Ribosome biogenesis in eukaryotes ECM-receptor interaction 
 Cytokine-cytokine receptor interaction Arrhythmogenic right ventricular 
cardiomyopathy (ARVC) 
 TNF signaling pathway Focal adhesion 
 NF-kappa B signaling pathway Hypertrophic cardiomyopathy (HCM) 
 Mineral absorption Pathways in cancer 
 MAPK signaling pathway Dilated cardiomyopathy 
 
Epithelial cell signaling in Heliobacter 
pylori infection 
PI3K-Akt signaling pathway 
 Legionellosis Axon guidance 
 Rheumatoid arthritis Rap1 signaling pathway 
 Phagosome Small cell lung cancer 
   
Biological 
functions 
  
 rRNA processing Homophilic cell adhesion 
 Maturation of SSU-rRNA Cell adhesion 
 Inflammatory response Extracellular matrix organization 
 Sodium ion transmembrane transport Synapse assembly 
 Ribosome biogenesis Nervous system development 
 (cellular) Response to 
lipopolysaccherides 
Calcium-dependent cell-cell adhesion 
 Response to cAMP Skeletal system development 
 Ion transport Response to drug 
 Ribosomal large subunit biogenesis Heart development 
 Mitochondrial translational termination Positive regulation of synapse assembly 
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Fig.3.48: Heatmap of Wnt genes changed by FOXP2 overexpression, CHIR treatment and FOXP2 
overexpression + CHIR treatment compared to control, colors indicate normalized log2 FC values, 
negative (blue), positive (red), neutral (white).  
 
 
 
Fig.3.49: q-PCR quantification of Wnt genes changed by FOXP2 overexpression, CHIR treatment or 
FOXP2 overexpression and CHIR treatment compared to control. 
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To investigate the effect of β-catenin on FOXP2Δ-helix, a part of the used cells were 
treated with CHIR and compared to cells only expressing FOXP2Δ-helix and cells only 
treated with CHIR. 
The gene sets being unique for FOXP2 plus CHIR and FOXP2Δ-helix plus CHIR were 
compared in order to find differences between the transcriptional activities of both 
FOXP2 constructs in presence of β-catenin. Thereby 963 upregulated genes were 
found to be similar in both data sets (Fig. 3.50).  
 
 
Fig 3.50: Left: Venn diagram showing the differences between FOXP2 Δ-helix, CHIR and FOXP2 Δ-helix 
+ CHIR, all compared to the control. Right: Volcano plot showing significantly up- (red) and 
downregulated (blue) genes of each condition compared to control. 
 
KEGG-pathway and GO term biological function analysis indicated ´signal 
transduction´ (196 genes, 5, 4e-3) as biological function and ´Cytokine-cytokine 
receptor interaction´ (59 genes, 3, 4e-5) as KEGG-pathway with most significant 
DEGs. In the data set of the most downregulated genes cell adhesion (113 genes, 5, 
5e-13) appeared as biological function and PI3K-Akt signaling pathway (70 genes, 2e-
6) as KEGG pathway with most significant DEGs. The heatmap visualization displays 
the effect of CHIR on the regulation of Wnt targets in presence or absence of FOXP2 
and FOXP2Δ-helix (Fig. 3.51). Q-PCR confirmed the RNA-Seq results (Fig. 3.52).  
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Tab.7: List of most significant up- and downregulated KEGG pathways and biological functions upon 
FOXP2Δ-helix overexpression + CHIR treatment compared to control. 
 
KEGG 
pathways 
Upregulated Downregulated 
 Ribosome biogenesis in eukaryotes Focal adhesion 
 Cytokine-cytokine receptor 
interaction 
Arrhythmogenic right ventricular 
cardiomyopathy (ARVC) 
 NF-kappa B signaling pathway ECM-receptor interaction 
 Rheumatoid arthritis PI3K-Akt signaling pathway 
 MAPK signaling pathway Axon guidance 
 Legionellosis Hypertrophic cardiomyopathy (HCM) 
 Nicotine addiction Dilated cardiomyopathy 
 Bile secretion Rap1 signaling pathway 
 TNF signaling pathway Pathways in cancere 
 Carbohydrate digestion and 
absorption 
Proteoglycans in cancer 
   
Biological 
functions 
  
 rRNA processing Homophilic cell adhesion 
 Inflammatory response Cell adhesion 
 Ion transport Extracellular matrix organization 
 Response to lipopolysaccheride Nervous system development 
 Sodium ion transmembrane transport Synapse assembly 
 Maturation of SSU-rRNA Calcium-dependent cell-cell adhesion 
 Neurotransmitter transport Negative regulation of viral genome 
replication 
 Cellular response to 
lipopolysaccharide 
Glycosaminoglycan catabolic process 
 Ion transmembrane transport Chemical synaptic transmission 
 Ribosomal large subunit biogenesis Axon guidance 
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Fig 3.51: Heatmap of Wnt genes changed in all conditions compared to control, colors indicate 
normalized log2 FC values, negative (blue), positive (red), neutral (white).  
 
 
 
Fig 3.52: q-PCR quantification of Wnt genes changed by all investigated conditions compared to control. 
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3.8 FOXP2IDR contains a phosphosite 
  
In addition to the already known phosphorylations, we were interested to find futher in 
the IDR of FOXP2, as PTMs are often occurring on IDRs. 
In order to detect PTMs such as phosphorylations, a few methods have been 
developed. Common ones are western blot, Enzyme-linked Immunosorbent assay 
(ELISA) or intracellular Flow Cytometry. They all have in common that the detection is 
sometimes not reliable, as the difference between a serine with or without phosphate 
group is difficult to detect. 
Mass spectrometry (MS) has been one of the methods of choice to detect protein post-
translational modifications as its high sensitivity and resolution. In principle, the method 
relies on the preliminary digestion of the protein sample and analysis of the resulting 
peptides. However, if different phosphorylation sites are in close proximity and on the 
same peptide after digestion, MS cannot identify the exact location of these sites. 
MS/MS might give the correct solution, but the instability of phosphate groups is often 
a problem. The quantitative analysis is also unreliable due to phosphate instability, and 
differential ionization efficiencies of the peptides. Therefore, MS usually is used with 
other biochemical techniques to give more accurate results of phosphorylated 
residues. 
 
NMR can be used to study PTMS from an analytical perspective, but also from a 
mechanistic, functional and structural point of view. Most of PTMs is forming by 
reversible, covalent additions of small, chemical entities, such as phosphate groups, 
acyl chains, alkyl chains, or various sugars, to the side-chains of individual protein 
residues89. Covalent PTMs introduce local alterations in the chemical environments of 
individual protein residues that can then be detected as characteristic chemical shift 
changes in a NMR spectrum. Enormous advantages of NMR for PTM detection is the 
exact localization of the PTM and the ability to follow those in real-time.  
 
In order to investigate, if, beside the known phosphorylation at S308, there is another 
phosphosite in the FOXP2IDR construct, a NMR-based technique using cell-lysate and 
isotope labeled recombinantly expressed protein was performed in order to detect the 
effect of the kinases in the lysate on the isotope labeled protein129. According to this 
technique, first isotope labeled protein is recorded for a reference spectrum, then lysate 
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or recombinant kinases are added to the labeled protein and further spectra are 
recorded allowing the detection and tracking of phosphorylations and other PTMs.  
 
 
Fig 3.53: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 100µM, left: human, right: chimpanzee), HEK-
293 T cell lysate (yellow, after 3h). 
 
We used 15N labeled human FOXP2IDR construct and recorded a reference 1H,15N 
HSQC. Then human cell lysate from HEK 293 T cells was added and 20 1H,15N HSQCs 
recorded successively. Those cells express FOXP2 endogenously, therefore kinases 
specific for FOXP2 phosphorylation are present. In order to avoid the removal of the 
phosphate group from a possible phosphorylated residue, phosphatase inhibitor within 
the lysate was used. As seen in figure 3.53, the 1H, 15N HSQC spectrum with lysate 
(blue) compared to the reference 1H, 15N HSQC spectrum (black) is different, as a 
signal appears on higher 1H chemical shift (around 8ppm) after around 3h. This signal 
is typical for a phosphorylation event, as the phosphate group on the residue is more 
electron negative then without and therefore a direct proof for the phosphorylation of 
the FOXP2IDR construct. In order to assign the phosphorylated residue, TEV-protease 
to cleave the Hexa-Histidine-tag from the 15N, 13C labeled FOXP2IDR was not used, then 
the NMR experiments with the lysate performed. Next, the tagged protein was 
repurified from the lysate using Ni-NTA beads and then cleaved the Hexa-Histidine-
tag from the protein and assigned the pure phosphorylated FOXP2IDR sample. 
Afterwards 3D NMR experiments were recorded on that sample in order to assign the 
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construct with the phosphorylated residue. After completing the assignment, we 
determined Ser330 as residue being phosphorylated in HEK-293 T cell lysate.  
To investigate, if this phosphorylation also occur in the chimpanzee protein, the 
experiments with the chimpanzee FOXP2IDR construct was repeated. Indeed, the same 
phosphorylation on position 330 appeared in HEK-cell lysate (Fig. 3.52 right).  
As FOXP2 is crucial for proper brain development, brain cells were an interesting 
environment to test, if this phosphorylation also occur in other cell types. As human 
brain is not accessible, brain tissue from mice were used. After lysing those, the 
phosphorylation assays were repeated with the human and chimpanzee FOXP2IDR 
construct (Fig. 3.54). Indeed, the same phosphorylation occurred at the same 
frequency in the spectra for both species in mice brain cell lysate (Fig. 3.55).  
 
 
Fig 3.54: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 100µM, left: human, right: chimpanzee), mice 
brain cell lysate (yellow, after 4h). 
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Fig 3.55: 1H 15N HSQC with 15N labeled FOXP2IDR (each 100µM, left: human, right: chimpanzee), in HEK 
293 T cell lysate (yellow, after 3h) overlaid with spectra recorded with mice brain cell lysate (purple, after 
4h). 
 
Now, we wanted to know, which kind of kinase this was and if it was the same in both 
cell types. In order to get an idea, we used a kinase prediction tool 
(kinasephos.mbc.nctu.edu.tw). By providing the sequence around Ser330, the 
software predicted protein kinase A (PKA), protein kinase C (PKC), Casein kinase 1 
(CK1) as possible kinases for this motif (R-R-X-S). In order to check, if one of those 
predicted kinase indeed is responsible for the phosphorylation of FOXP2 S330, a 
recombinantly expressed protein kinase A was purchased (Promega, V5161). Protein 
kinase A, also known as cAMP-dependent kinase, is one of the most studied kinases 
and belongs to the serine/threonine kinases. It is mainly active in the regulation of the 
catabolism, but also important in cell proliferation by acting on transcription factors130 
and occurs in cytoplasm and nucleus. In order to investigate the effect of the kinase 
on FOXP2 a reference 1H, 15N HSQC spectrum with 15N labeled FOXP2IDR 
human/chimpanzee was recorded. Then, 400 units of PKA were added to the sample 
and after incubation for one hour another 1H, 15N HSQC spectrum was recorded (Fig. 
3.56). Indeed, a peak at higher chemical shift (8.85 ppm at 1H axis) appeared 
compared to the reference spectrum, indicating the phosphorylation of an amino acid 
in both species.  
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Fig 3.56: 1H 15N HSQC with 15N labeled FOXP2IDR (black, 100µM, left: human, right: chimpanzee), PKA 
titrations (yellow, after 40min). 
 
By comparing the spectra with the spectra of the cell lysate-experiments (Fig. 3.57), 
we concluded, that the phosphorylation is also taking place at Ser330. These data 
indicate, that it’s PKA, which is responsible for the phosphorylation of S330 of FOXP2. 
PKA indeed is expressed in HEK-293 T cells and also known to be present in brain 
cells (see expression levels at www.proteinatlas.org).  
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Fig 3.57: 1H 15N HSQC with 15N labeled FOXP2IDR  (each 100µM, left: human, right: chimpanzee), in 
HEK 293 T cell lysate (yellow, after 3h) overlaid with spectra recorded with PKA (green, after 40min). 
 
To investigate the effect of the phosphorylation on binding partners, a phospho-
mimicking mutant of FOXP2IDR was designed by replacing the Ser330 to a Glutamic 
acid (FOXP2S330E). Hereby a similar structure of the phosphorylated serine is created 
by mutating the serine to a glutamic acid, as this amino acid harbors a negative 
charge131.  
As phosphorylations can have a regulatory effect on transcription factors, we tested 
the effect of the phospho-mimicking mutant on the newly discovered interaction 
partners. First, a 1H, 15N HSQC spectrum of 15N labeled FOXP2S330E  was recorded  as 
reference. Then increasing amounts of unlabeled β-catenin141-305 was added (Fig. 
3.58). 
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Fig 3.58: Left: 1H 15N HSQC with 15N labeled FOXP2S330E (black, 100µM), titrations with β-catenin141-305 
(green, µM). Right: Intensity plot indicating the affected residues around region with α-helical propensity. 
 
According to those results, the phospho-mimicking mutant is not affecting the binding 
to β-catenin as similar CSPs were observed than with FOXP2IDR. Then a possible 
effect of the phospho-mimicking mutant on other newly discovered FOXP2 interaction 
partners of this project was investigated (i.e. LEF1, ICAT). After recording a reference 
spectrum with 15N labeled FOXP2S330E increasing amounts of LEF288-399 (Fig. 3.59) or 
ICAT (Fig. 3.60), were added. 
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Fig 3.59: Left: 1H 15N HSQC with 15N labeled FOXP2S330E (black, 100µM), titrations with LEF288-399 
(blue, µM). Right: CSP plot indicating the affected residues around region with α-helical propensity. 
 
 
Fig 3.60: Left:  1H 15N HSQC with 15N labeled FOXP2S330E (black, 100µM), titrations with ICAT (purple, 
µM). Right: CSP plot indicating the affected residues around region with α-helical propensity. 
 
ICAT and LEF288-399 were still binding to the IDR despite the negative charge at position 
330. Next, it was tested, if the FH of FOXP2 is still binding to FOXP2S330E (Fig. 3.61).  
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Fig 3.61: Left: 1H 15N HSQC with 15N labeled FOXP2S330E (black, 100µM), titrations with FOXP2FH 
(coral, 400µM). Right: CSP plot indicating the affected residues around region with α-helical propensity.  
 
Indeed, also here the interaction still took place. This indicates, that for the interaction 
partners I found in my thesis binding to the IDR of FOXP2, the phosphorylation does 
not seem to have an effect. These results could be due to the fact that the 
phosphorylation site is not located close to the region with α-helical propensity (residue 
264-272), thus the impact of the phosphorylation on binding partners binding to the 
region with α-helical propensity might be less likely.   
 
3.9 R553H mutant binds to DNA 
 
In order to test which effect the mutant responsible for the speech disorder has on 
protein-protein and protein-DNA interactions, another FH construct was designed 
including the point mutation (FOXP2R553H). The first differences between wildtype and 
mutant already appeared during the expression and purification. While the wildtype FH 
was completely soluble after elution of the NiNTA step, the mutant was mainly 
insoluble. To solve this, lysis buffer with high concentrations of Urea was used, in order 
to denaturate the protein and making it soluble. To confirm the proper refolding of the 
FH after removal of Urea, a 1H, 15N HSQC was recorded and compared to the wildtype 
spectrum (Fig. 3.62). Indeed, the forkhead of the mutant had similar signals than the 
wildtype FH indicating that the FOXP2R553H refolded during purification.  
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Fig.3.62: 1H, 15N HSQC of the FOXP2R553H compared to the wildtype FH proofing the proper refolding of 
the FH-mutant.  
 
 
Fig. 3.63: Isothermal calorimetry comparison of the binding between FOXP2FH and DNA (left) and 
FOXP2R553H and DNA (right). 
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Also the behavior of wildtype and mutant differed in phosphate buffer, when DNA was 
added. While the wildtype remained soluble, the mutant precipitated. Therefore 
HEPES buffer was used, as the mutant did not show precipitation in this buffer 
composition. Additionally, while the wildtype FH was binding to a heparin column due 
to its global positive charge, the mutant did not bind. This can be explained, as the pI 
of the wildtype is 8.5 at a pH of 7, the pI of the mutant is 7.6, therefore the mutant 
protein is less positively charged than the wildtype protein. According to these 
information, one could conclude, that the DNA binding affinity of the mutant is changed 
due to its point mutation. A study showed that the mutant where not showing any DNA 
binding in a luciferase-assay75.  
As in-cell interactions must be rather strong to be detected, in vitro interactions can 
also be detected in µM range. Thus, we tested if the mutant is binding to DNA using 
ITC. Interestingly, by titrating DNA into FOXP2R553H the ITC-derived dissociation 
constants corresponding to DNA binding to either WT or mutated FOXP2FH are similar 
(864nM vs 943nM) compared to the FH wildtype (Fig. 3.63). Thus, in our experiments, 
no difference between WT and mutant could be detected. 
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4 Discussion 
 
4.1 FOXP2 contains two protein-protein interaction sites 
 
FOXP2 belongs to a broad family of transcription factors, which are known to be 
involved in embryonal development. As it is responsible for various biological functions, 
a tight regulation of its transcriptional activity must take place. This can occur by protein 
partners interacting and thus influencing the activity of FOXP2. So far, only few 
interaction partners have been identified, their role in regulation of FOXP2 remains 
elusive. In studies using experiments such as Co-IP CTBP179, NFAT, PIAS175, 
TBR1132, FOXP1 and FOXP431 have been identified to interact with FOXP2. 
Additionally, variations of homo- and heterodimerization of FOXP1, FOXP2 and 
FOXP4 have been shown to influence significantly the expression of known FOXP2 
targets involved in embryonal neuronal development31.  Another mechanism of 
regulation are post-translational modifications. FOXP2 harbour a few phosphorylation 
sites, an ubiquitination site and a sumoylation site. Only for one phosphorylation the 
effect is known so far92.  
In this thesis I first investigated an IDR within FOXP2, which is located between the 
polyQ-region and the zinc finger (residue 247-331) and might play a crucial role in the 
evolutionary development of humans, as both amino acids, which differ between 
human and chimpanzee, are located in this IDR. Indeed, a region with α-helical 
propensity was found, which thus might function as protein-protein interaction site. 
IDRs are crucial players in regulation of proteins, as they facilitate binding to other 
partners due to less flexibility and solvent exposure and can influence the 
regulation133,134. This α-helical propensity was observed in both species (human and 
chimpanzee), indicating that the two different amino acids do not affect the formation 
of the α -helix and thus behave similarly.  
To determine if this alpha-helix indeed facilitate protein protein interactions NMR was 
used as sensitive methods for protein-protein interactions detection and indeed we 
determined various proteins as novel interactions partners to the IDR of FOXP2 with 
α-helical propensity. The transcription factor LEF1 and the regulator ICAT, both 
involved in the Wnt-pathway, are directly interacting with the IDR of FOXP2, indicating 
that those interactions might be competitive under certain circumstances. These 
interactions could be a competitive mechanism in order to regulate transcription of 
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targets, such as the Wnt targets. Thereby FOXP2IDR could interact with the DNA-
binding domain of LEF1 and thereby changing the transcriptional activity of LEF1. Then 
the FH of FOXP2 could thereby bind to DNA and regulate the transcription of other 
genes. All recorded interactions were affecting the residues around the previously 
determined α-helix, indicating the important function of this secondary structure 
element in the interaction network of FOXP2. As already known, FOXP1 and FOXP3 
are involved in Wnt signaling pathway93,94, thus we tested a possible link between 
FOXP2 and this pathway, which is important in embryonal development and adult 
homeostasis. Thereby we discovered β-catenin as novel interaction partner of FOXP2. 
Using NMR two binding sites were determined, the FH domain and the IDR between 
PolyQ-region and zinc finger. Using different constructs of β-catenin the first part of the 
armadillo region of β-catenin was determined to interact with the IDR of FOXP2 and 
the disordered N- and C-termini of β-catenin are interacting with the FH of FOXP2. 
These results indicate, that one molecule of β-catenin could bind to one molecule of 
FOXP2. Interestingly, the N- and C-terminus of β-catenin bind to the same region at 
the FH but interact with different affinities. Then, the interaction was proven with 
endogenous FOXP2 and β-catenin via Co-IP in human cells, whereby it was shown 
that FOXP2 and β-catenin interact in HEK-293-T cells confirming a – at least - indirect 
interaction between both proteins. Using different constructs we could show with Co-
IP, that β-catenin has at least two binding sites on FOXP2 confirming our NMR data. 
With ITC the binding between FH and the C-terminus of β-catenin was determined as 
slightly stronger than the binding between FH and N-terminus, which indicates that the 
interaction between FH and C-terminus is the favorable interaction and only upon 
interaction of the C-terminus with another protein partner might facilitate the binding 
between FH and N-terminus. This competitive element thus might be a regulatory 
function on the transcriptional activity of FOXP2. Another possibility for this competitive 
network might be other interaction partners of FOXP2, such as other FOX proteins. In 
absence of those, β-catenin might affect the transcriptional activity of FOXP2 by 
binding weakly to the FH domain. In presence of other interaction partners, β-catenin 
might bind to those because of possible higher affinities leading to a disruption of 
affecting FOXP2 and its function. A further possibility would be, that other proteins 
have a stronger affinity to the FH of FOXP2 than β-catenin and thus compete with it 
for binding to FOXP2. In line with this hypothesis, FOXP2 could compete with TCF for 
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interaction with β-catenin. The transcriptional activity of TCF might be decreased, if 
FOXP2 is overexpressed in the cells and interacting with β-catenin. 
Considering the fact, that β-catenin is binding to two binding sites, which are located 
far from each other, a possible link between both binding sites was investigated. 
Indeed, NMR experiments have shown, that the IDR is interacting with the FH domain 
creating a backfold within the protein. If this interaction is happening as intramolecular 
or intermolecular could not be determined, but given that fact, that the concentration of 
FOXP2 in the nucleus must be in low µM range to make an intermolecular interaction 
possible, the intramolecular interaction was taken as the most likely state.  This 
interaction provides variations of possible regulatory elements. In order to test the 
simplest idea, that the IDR backfold on the FH domain affects the DNA binding affinity 
of FOXP2, NMR and ITC experiments were performed. Indeed, a difference in binding 
affinity was observed, if an artificial construct containing the FH linked to the IDR via a 
GS-linker was titrated with DNA compared to the FH alone. The data have shown that 
the DNA binding is stronger in presence of the IDR, indicating that this IDR acts as a 
regulatory element in FOXP2 function. As the binding between FH and the IDR of 
FOXP2 is weak, this interaction might only take place, when there are no other proteins 
binding to the FH or the IDR itself, except their affinity is lower than the one between 
FH and IDR. Thus other proteins might interrupt this intramolecular interaction by either 
binding to the FH or to the IDR of FOXP2 and thus regulate the function of FOXP2. 
Another function of this backfold might be the translocation of cofactors affecting the 
transcriptional activity of FOXP2. This hypothesis is supported by our findings, that the 
α-helix within the IDR of FOXP2 is an interaction site for various proteins and thus 
might play an important role in recruiting other proteins to the FH and thereby affecting 
the transcriptional activity.  
 
4.2 FOXP2 is involved in the regulation of the Wnt-signaling pathway  
 
In order to investigate the effect of β-catenin and the intramolecular backfold on the 
transcriptional activity of FOXP2, RNA Seq was performed with six different conditions.  
By overexpressing FOXP2 in U2OS cells more genes were found to be downregulated 
than upregulated, which fits with other studies claiming FOXP2 as transcriptional 
repressor24,135. Thus the data in this thesis confirm the effect of FOXP2 on Wnt-
signaling. Beside this pathway various pathways involved in brain development, 
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morphology and learning were significantly changed upon FOXP2 overexpression, 
such as cell adhesion molecules, Hippo signaling and Wnt signaling. Based on those 
data the Wnt-signaling pathway was found to be significantly downregulated upon 
FOXP2 overexpression in U2OS cells which has been shown before136,137. Various 
other FOX proteins are already known to regulate Wnt pathway. Beside FOXP193 and 
FOXP394, also FOXK1 and FOXK2138 have been found to be linked to Wnt-signaling 
regulation. Thus FOX transcription factors play a crucial role in this important signaling 
way and thus understanding the molecular mechanisms behind such networks might 
help to understand the development of diseases such as cancer and Alzheimers’ 
disease.  
In order to investigate the effect of β-catenin on the transcriptional activity of FOXP2 
cells overexpressing FOXP2 were treated with CHIR, a chemical inducing the nuclear 
localization of β-catenin. With this treatment, FOXP2 and β-catenin were both localized 
in the nucleus of the cell and thus could interact with each other. Indeed, we observed 
that in the condition of FOXP2 overexpression plus CHIR treatment the number of 
upregulated genes increased significantly compared to the condition of FOXP2 
overexpression without CHIR treatment. This results could proof that, while Wnt 
signaling is inactive, FOXP2 acts as a repressor and upon Wnt activation, β-catenin   
concentrations increase in the nucleus and inhibit FOXP2 activity leading to loss of its 
function as transcriptional repressor. Additionally, by comparing the targets changed 
upon FOXP2 overexpression alone and the condition of FOXP2 overexpression plus 
β-catenin induction, many differences occurred. These data indicate that the 
transcriptional activity of FOXP2 is affected by the presence of β-catenin and thus other 
targets are regulated by FOXP2. Nevertheless, it cannot be proven, that these changes 
occurred because of the direct interaction of both proteins, but the effect can also come 
from differences in cofactors and affinities. An option would be that β-catenin binds to 
proteins, which were affecting the activity of FOXP2 in absence of β-catenin, thus the 
effect of those on FOXP2 is disbanded and the transcriptional activity changed. 
Further results in this thesis show the direct interaction of the IDR to the FH domain of 
FOXP2, forming probably a backfold-like conformation. In order to find proofs for a 
regulatory effect of the IDR on FOXP2 activity RNA-Seq was performed using a FOXP2 
variant lacking this α-helix. Indeed, various differences were found by comparing this 
data set to the data set of the FOXP2FL overexpression. For a few genes it seems that 
even they are downregulated by FOXP2FL, the variant lacking the α-helix leads to an 
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further increased transcriptional repression. However, by comparing the by the variant 
and FOXP2FL significantly regulated genes we found that 30% of the downregulated 
and 33% of upregulated genes differ between both conditions. Interestingly, we found 
that the Wnt signaling pathway is suppressed less by the FOXP2Δ-helix construct than 
by FOXP2FL. Thus, FOXP2FL activity seems to be regulated by the α-helix as the 
variant lacking this secondary structure element regulates various genes which are not 
regulated by the full-length transcription factor. These data suggest that the α-helix is 
indeed a regulatory element in FOXP2 itself as FOXP2FL is suppressing certain 
pathways such as the Wnt-signaling pathway more efficient than FOXP2 lacking the 
α-helix. Thus this region might indeed function as interaction side for various co-factors 
such as β-catenin to the FH and thus regulating the activity of FOXP2. Additionally, the 
newly discovered backfold mechanism might play a role in the regulation of FOXP2 by 
affecting the DNA binding affinities on FOXP2 target genes. In this thesis we 
discovered while using ITC that an artificial construct, containing the FH and the α-
helix, is binding with higher affinities to a DNA target than the FH alone. This must not 
be true for other DNA targets but indicates that the IDR indeed is regulating the DNA 
binding affinities of FOXP2. For other targets the interaction to DNA might be disturbed 
by the IDR or co-factors which are recruited to the FH via the intramolecular interaction. 
To obtain more insight in this mechanisms, other studies must take place in order to 
understand how the backfold is changing the transcriptional activity of FOXP2.   
 
4.3 FOXP2 is phosphorylated by protein kinase A 
 
Beside novel interaction partners, which regulate FOXP2 activity, also PTMs such as 
phosphorylation were investigated. As IDRs in transcription factors are solvent-
accessible, they are often target of PTMs and thus regulated. In this thesis FOXP2IDR 
was investigated to find possible novel PTMs. This region was chosen, as it is 
intrinsically disordered and additionally, it contains the two amino acids which differ 
between human and chimpanzee, thus another regulation mechanism might be an 
interesting and important feature between both species. In this region, already one 
phosphorylation is known in humans at residue Ser308 (https://www.phosphosite.org), 
but the effect of this phosphorylation is still unknown. Using HEK-293T-cell lysate and 
NMR, a new phosphorylation site was discovered at Ser330, in both human and 
chimpanzee FOXP2. Interestingly, this phosphorylation is located close to the residue, 
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which are different between human and chimpanzee (N303T, S325N)45. In our NMR 
experiments this phosphorylation did not change the binding to interaction partners, 
which were discovered earlier in this thesis. It neither changed the intramolecular 
interaction to the FH, thus a direct effect on the DNA binding ability of FOXP2 was not 
observed. Thus, our in vitro data do not show any effect of this phosphorylation event 
in FOXP2 regulation at molecular level. However, in cell assays were not performed, 
thus it remains open, whether this phosphorylation is affecting the transcriptional 
activity of FOXP2. Thus RNA-Seq experiments with cells either expressing FOXP2 as 
phospho-mimicking mutant or a mutant containing an alanine instead of the 
phosphorylated residue to prevent phosphorylation by endogenous kinases could be 
carried out, in order to investigate the effect of the phosphorylation on the 
transcriptional activity of FOXP2.  
Further on, PKA was determined as possible responsible kinase. PKA is a kinase, 
which is dependent on cellular levels of cAMP and phosphorylates proteins exposing 
the motif arginine-arginine-X-serine. By these phosphorylations proteins can be 
activated or deactivated. As PKA has various proteins as targets, its function varies 
with the cell type its occurring into. A few examples are stimulating glycogenolysis, 
glycolysis and epithelial sodium channel and affecting renin secretion. Disfunctions of 
this kinase are linked to various diseases such as cardiovascular diseases and 
cancer139. As FOXP2 is mainly expressed in the brain, the phosphorylation of PKA 
might play a role in the reward system by transfer/translate the dopamine signal into 
cells in the nucleus accumbens140. Another possibility would be its role in memory 
formation, as PKA knockdown in Drosophila melanogaster showed decreased learning 
ability and memory retention141. Thus, PKA might play a role on FOXP2 while learning. 
As the motif around Ser330 is highly conserved in mammals, birds, reptiles and 
amphibia, this phosphorylation occurs in various other species, where it could be 
responsible for memory and learning. The cellular effect of the phosphorylation of 
FOXP2 by this kinase could not be determined in this thesis, thus further work must be 
done. It would be possible, that this phosphorylation increases/decreases the binding 
affinity to certain partners, which then regulate the transcriptional activity of FOXP2 
and thus its function.  
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Fig.4: possible model of the regulation of FOXP2 by β-catenin. 
 
Concluding, in this thesis I found the Wnt signaling pathway to be regulated by FOXP2 
for the first time. Thus three of the four members of the FOXP family are linked to this 
pathway which acts in embryonal development and cancer. I could map two interaction 
sites of β-catenin to FOXP2, these results reveal an evolutionarily conserved function 
of β-catenin that is independent of TCF signaling. Both binding sites seem to be 
important for the function and regulation of FOXP2 activity as I observed several 
changes in regulated pathways if the first binding site was lacking. Thus we come to 
the hypothesis that the α-helix in the IDR acts as a recruiter for co-factors (Fig. 4). 
Those play crucial roles in signal transduction and regulation9. This regulatory element 
seems also to be important in the regulation by β-catenin, as we found various genes 
changed in expression when overexpressing cells with FOXP2 and treated with CHIR 
compared to cells overexpressing FOXP2Δ-helix with CHIR treatment, leading to other 
biological and molecular functions.  
Concluding we found regulatory elements within FOXP2 which must be closer 
determined. We found β-catenin regulating FOXP2 activity, thus further studies on this 
pathway should be carried on.  
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6 Appendix 
 
6.1 Protein sequences 
 
6.1.1 FOXP2FL 
MMQESATETISNSSMNQNGMSTLSSQLDAGSRDGRSSGDTSSEVSTVELLHLQQQQALQAARQLLL
QQQTSGLKSPKSSDKQRPLQVPVSVAMMTPQVITPQQMQQILQQQVLSPQQLQALLQQQQAVMLQ
QQQLQEFYKKQQEQLHLQLLQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
HPGKQAKEQQQQQQQQQQLAAQQLVFQQQLLQMQQLQQQQHLLSLQRQGLISIPPGQAALPVQSL
PQAGLSPAEIQQLWKEVTGVHSMEDNGIKHGGLDLTTNNSSSTTSSNTSKASPPITHHSIVNGQSSVL
SARRDSSSHEETGASHTLYGHGVCKWPGCESICEDFGQFLKHLNNEHALDDRSTAQCRVQMQVVQ
QLEIQLSKERERLQAMMTHLHMRPSEPKPSPKPLNLVSSVTMSKNMLETSPQSLPQTPTTPTAPVTPI
TQGPSVITPASVPNVGAIRRRHSDKYNIPMSSEIAPNYEFYKNADVRPPFTYATLIRQAIMESSDRQLTL
NEIYSWFTRTFAYFRRNAATWKNAVRHNLSLHKCFVRVENVKGAVWTVDEVEYQKRRSQKITGSPTL
VKNIPTSLGYGAALNASLQAALAESSLPLLSNPGLINNASSGLLQAVHEDLNGSLDHIDSNGNSSPGCS
PQPHIHSIHVKEEPVIAEDEDCPMSLVTTANHSPELEDDREIEEEPLSEDLE 
 
6.1.2 FOXP2247-715 
GQAALPVQSLPQAGLSPAEIQQLWKEVTGVHSMEDNGIKHGGLDLTTNNSSSTTSSNTSKASPPITHH
SIVNGQSSVLSARRDSSSHEETGASHTLYGHGVCKWPGCESICEDFGQFLKHLNNEHALDDRSTAQ
CRVQMQVVQQLEIQLSKERERLQAMMTHLHMRPSEPKPSPKPLNLVSSVTMSKNMLETSPQSLPQT
PTTPTAPVTPITQGPSVITPASVPNVGAIRRRHSDKYNIPMSSEIAPNYEFYKNADVRPPFTYATLIRQAI
MESSDRQLTLNEIYSWFTRTFAYFRRNAATWKNAVRHNLSLHKCFVRVENVKGAVWTVDEVEYQKR
RSQKITGSPTLVKNIPTSLGYGAALNASLQAALAESSLPLLSNPGLINNASSGLLQAVHEDLNGSLDHID
SNGNSSPGCSPQPHIHSIHVKEEPVIAEDEDCPMSLVTTANHSPELEDDREIEEEPLSEDLE 
 
6.1.3 FOXP2342-714 
LYGHGVCKWPGCESICEDFGQFLKHLNNEHALDDRSTAQCRVQMQVVQQLEIQLSKERERLQAMMT
HLHMRPSEPKPSPKPLNLVSSVTMSKNMLETSPQSLPQTPTTPTAPVTPITQGPSVITPASVPNVGAIR
RRHSDKYNIPMSSEIAPNYEFYKNADVRPPFTYATLIRQAIMESSDRQLTLNEIYSWFTRTFAYFRRNA
ATWKNAVRHNLSLHKCFVRVENVKGAVWTVDEVEYQKRRSQKITGSPTLVKNIPTSLGYGAALNASL
QAALAESSLPLLSNPGLINNASSGLLQAVHEDLNGSLDHIDSNGNSSPGCSPQPHIHSIHVKEEPVIAE
DEDCPMSLVTTANHSPELEDDREIEEEPLSEDLE 
      
6.1.4 FOXP2504-715 
RPPFTYATLIRQAIMESSDRQLTLNEIYSWFTRTFAYFRRNAATWKNAVRHNLSLHKCFVRVENVKGA
VWTVDEVEYQKRRSQKITGSPTLVKNIPTSLGYGAALNASLQAALAESSLPLLSNPGLINNASSGLLQA
VHEDLNGSLDHIDSNGNSSPGCSPQPHIHSIHVKEEPVIAEDEDCPMSLVTTANHSPELEDDREIEEEP
LSEDLE 
 
6.1.5 FOXP2IDR 
GQAALPVQSLPQAGLSPAEIQQLWKEVTGVHSMEDNGIKHGGLDLTTNNSSSTTSSNTSKASPPITHH
SIVNGQSSVLSARRDSSSHEETGASHT 
 
6.1.6 FOXP2IDR_Δ264-272 
GQAALPVQSLPQAGLSPTGVHSMEDNGIKHGGLDLTTNNSSSTTSSNTSKASPPITHHSIVNGQSSVL
SARRDSSSHEETGASHT 
 
6.1.7 FOXP2S330E 
GQAALPVQSLPQAGLSPAEIQQLWKEVTGVHSMEDNGIKHGGLDLTTNNSSSTTSSNTSKASPPITHH
SIVNGQSSVLSARRDESSHEETGASHT 
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6.1.8 FOXP2FH 
RPPFTYATLIRQAIMESSDRQLTLNEIYSWFTRTFAYFRRNAATWKNAVRHNLSLHKCFVRVENVKGA
VWTVDEVEYQKRRSQKITGSPTL 
 
6.1.9 FOXP2FH-IDR 
RPPFTYATLIRQAIMESSDRQLTLNEIYSWFTRTFAYFRRNAATWKNAVRHNLSLHKCFVRVENVKGA
VWTVDEVEYQKRRSQGGSGGSGGSGGSQAGLSPAEIQQLWKEVTGVHS 
 
6.1.10 FOXP2R553H 
RPPFTYATLIRQAIMESSDRQLTLNEIYSWFTRTFAYFRRNAATWKNAVHHNLSLHKCFVRVENVKGA
VWTVDEVEYQKRRSQKITGSPTL 
 
6.1.11 β-cateninFL 
MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYE
WEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQ
MLKHAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAI
VRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQE
GAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLL
WTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGT
LVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTS
RHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLV
RAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENI
QRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVEL
TSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGH
HPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL 
 
6.1.12 β-catenin1-140 
MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYE
WEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQ
MLKHAVVNLI 
 
6.1.13 β-catenin141-305 
NYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTND
VETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLA
GGLQKMVALLNKTNVKFLAITTDCLQILA 
 
6.1.14 β-catenin666-781 
KPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGM
DPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL 
 
6.1.15 LEF1-299 
MPQLSGGGGGGGGDPELCATDEMIPFKDEGDPQKEKIFAEISHPEEEGDLADIKSSLVNESEIIPASN
GHEVARQAQTSQEPYHDKAREHPDDGKHPDGGLYNKGPSYSSYSGYIMMPNMNNDPYMSNGSLSP
PIPRTSNKVPVVQPSHAVHPLTPLITYSDEHFSPGSHPSHIPSDVNSKQGMSRHPPAPDIPTFYPLSPG
GVGQITPPLGWQGQPVYPITGGFRQPYPSSLSVDTSMSRFSHHMIPGPPGPHTTGIPHPAIVTPQVK
QEHPHTDSDLMHVKPQHEQRKEQEPKRPHI 
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6.1.16 LEF288-399 
QRKEQEPKRPHIKKPLNAFMLYMKEMRANVVAECTLKESAAINQILGRRWHALSREEQAKYYELARK
ERQLHMQLYPGWSARDNYGKKKKRKREKLQESASGTGPRMTAAYI 
 
6.1.17 ICAT 
MNREGAPGKSPEEMYIQQKVRVLLMLRKMGSNLTASEEEFLRTYAGVVNSQLSQLPPHSIDQGAEDV
VMAFSRSETEDRRQ 
 
 
6.2 Top 10 up/downregulated genes of RNA Seq data of each condition compared to 
control, log2 fold change in brackets 
 Upregulation Downregulation 
FOXP2 FOXP2 (13) PRND (-10.5) 
 MMP1 (11.3) KANK4 (-9.3) 
 LPAR6 (11.2) HTR2A (-9.2) 
 CTD-2532D12.4 (9.4) SOSTDC1 (-8.9) 
 MYCT1 (9.3) AC074289.1 (-8.5) 
 IL24 (9) MYOCD (-8.1) 
 ENAM (9) CXCL14 (-8.1) 
 AF121898.3 (9) FOXS1 (-8) 
 SPRR2D (8.6) RP11-798L4.1 (-7.9) 
 MAL (8.6) ABCB5 (-7.9) 
 
 Upregulation Downregulation 
CHIR GZMB (12) MYOCD (-9.2) 
 MUCL1 (11.4) FOXS1 (-8.8) 
 CXCL6 (10.7) NWD1 (-8.5) 
 MTHFD2P1 (10.7) GALNt15 (-8.3) 
 C1orf168 (10.1) CD180 (-8.1) 
 LINC00161 (9.9) YPEL4 (-7.9) 
 RP11-415C15.2 (9.8) SYT8 (-7.7) 
 RP11-95P13.3 (9.8) HTR2A (-7.2) 
 CST1 (9.6) TNFSF15 (-7.2) 
 FILIP1 (9.5) CTD-2334D19.1 (-6.8) 
 
 Upregulation Downregulation 
FOXP2Δhelix FOXP2 (12.6) PRND (-9.7) 
 MAL (11.4) PLP1 (-9.7) 
 LPAR6 (11) KANK4 (-9.1) 
 MMP1 (10.9) SERPINB2 (12) 
 MUC5AC (9.7) CCDC67 (-8) 
 AGXT (9.5) CXCL14 (-7.8) 
 MYCT1 (9.4) RP11-798L4.1 (-7.7) 
 CTD-2532D12.4 (9.1) GABRR1 (-7.7) 
 LINC00659 (9) AC074289.1 (-7.6) 
 SRL (8.9) MYOCD (-7.6) 
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 Upregulation Downregulation 
FOXP2 + FOXP2 (14) PRND (-10.5) 
CHIR LPAR6 (13) SOSTDC1 (-10) 
 MYCT1 (12.1) IGFBP5 (-9.1) 
 SERPINB2 (12) PLP1 (-8.2) 
 RP11-753N8.1 (11.9) HTR2A (-8) 
 SPRR2D (11.3) CXCL14 (-8) 
 CTD-2532D12.4 (11.2) SLC2A12 (-8) 
 MAL (11.2) AC074289.1 (-7.9) 
 MMP1 (10.8) R3HDML (-7.8) 
 GZMB (10.8) GALNT15 (-7.6) 
 
 Upregulation Downregulation 
FOXP2Δhelix +  FOXP2 (13.8) PRND (-9.2) 
CHIR MAL (12.7) SOSTDC1 (-8.7) 
 LPAR6 (12.6) IGFBP5 (-8.7) 
 MYCT1 (11.9) ABCB5 (-8.3) 
 RP11-753N8.1 (11.9) APOL4 (-8.2) 
 MUC5AC (11.6) GABRR1 (-7.7) 
 AGXT (11.5) RP1.193H18.2 (-7.7) 
 GZMB (11.5) CXCL14 (-7.7) 
 SPRR2D (10.7) FABP7 (-7.5) 
 MUCL1 (10.5) KIAA1210 (-7.5) 
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